| Year |
Citation |
Score |
| 2024 |
Deng F, Bueber MA, Cao Y, Tang J, Bai X, Cho Y, Lee J, Lin Z, Yang Q, Keshavan MS, Stone WS, Qian M, Yang LH, Phillips MR. Assessing social cognition in patients with schizophrenia and healthy controls using the reading the mind in the eyes test (RMET): a systematic review and meta-regression. Psychological Medicine. 1-27. PMID 38173096 DOI: 10.1017/S0033291723003501 |
0.329 |
|
| 2023 |
Tandon R, Nasrallah H, Akbarian S, Carpenter WT, DeLisi LE, Gaebel W, Green MF, Gur RE, Heckers S, Kane JM, Malaspina D, Meyer-Lindenberg A, Murray R, Owen M, Smoller JW, ... ... Keshavan M, et al. The schizophrenia syndrome, circa 2024: What we know and how that informs its nature. Schizophrenia Research. 264: 1-28. PMID 38086109 DOI: 10.1016/j.schres.2023.11.015 |
0.369 |
|
| 2023 |
Hegde S, Keshavan MS. The brain on the beat: How music may heal schizophrenia. Schizophrenia Research. 261: 113-115. PMID 37717508 DOI: 10.1016/j.schres.2023.08.032 |
0.308 |
|
| 2023 |
McGuigan BN, Santini T, Keshavan MS, Prasad KM. Gene Expressions Preferentially Influence Cortical Thickness of Human Connectome Project Atlas Parcellated Regions in First-Episode Antipsychotic-Naïve Psychoses. Schizophrenia Bulletin Open. 4: sgad019. PMID 37621304 DOI: 10.1093/schizbullopen/sgad019 |
0.3 |
|
| 2023 |
Lizano P, Kiely C, Mijalkov M, Meda SA, Keedy SK, Hoang D, Zeng V, Lutz O, Pereira JB, Ivleva EI, Volpe G, Xu Y, Lee AM, Rubin LH, Kristian Hill S, ... ... Keshavan MS, et al. Peripheral inflammatory subgroup differences in anterior Default Mode network and multiplex functional network topology are associated with cognition in psychosis. Brain, Behavior, and Immunity. PMID 37506949 DOI: 10.1016/j.bbi.2023.07.014 |
0.757 |
|
| 2023 |
Prasad KM, Muldoon B, Theis N, Iyengar S, Keshavan MS. Multipronged investigation of morphometry and connectivity of hippocampal network in relation to risk for psychosis using ultrahigh field MRI. Schizophrenia Research. 256: 88-97. PMID 37196534 DOI: 10.1016/j.schres.2023.05.002 |
0.301 |
|
| 2023 |
Keshavan MS, Eack SM. Cognitive enhancement interventions are effective for schizophrenia: why not provide them early? World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 22: 326-327. PMID 37159373 DOI: 10.1002/wps.21091 |
0.31 |
|
| 2023 |
Cetin-Karayumak S, Lyall AE, Di Biase MA, Seitz-Holland J, Zhang F, Kelly S, Elad D, Pearlson G, Tamminga CA, Sweeney JA, Clementz BA, Schretlen D, Stegmayer K, Walther S, Lee J, ... ... Keshavan M, et al. Characterization of the extracellular free water signal in schizophrenia using multi-site diffusion MRI harmonization. Molecular Psychiatry. PMID 37095352 DOI: 10.1038/s41380-023-02068-1 |
0.368 |
|
| 2023 |
Jester DJ, Thomas ML, Sturm ET, Harvey PD, Keshavan M, Davis BJ, Saxena S, Tampi R, Leutwyler H, Compton MT, Palmer BW, Jeste DV. Review of Major Social Determinants of Health in Schizophrenia-Spectrum Psychotic Disorders: I. Clinical Outcomes. Schizophrenia Bulletin. PMID 37022779 DOI: 10.1093/schbul/sbad023 |
0.33 |
|
| 2023 |
Tucci AA, Schroeder A, Noël C, Shvetz C, Yee J, Howard AL, Keshavan MS, Guimond S. Social cognition in youth with a first-degree relative with schizophrenia: A systematic scoping review. Psychiatry Research. 323: 115173. PMID 36989908 DOI: 10.1016/j.psychres.2023.115173 |
0.324 |
|
| 2023 |
Zhang L, Lizano P, Xu Y, Rubin LH, Lee AM, Lencer R, Reilly JL, Keefe RSE, Keedy SK, Pearlson GD, Clementz BA, Keshavan MS, Gershon ES, Tamminga CA, Sweeney JA, et al. Peripheral inflammation is associated with impairments of inhibitory behavioral control and visual sensorimotor function in psychotic disorders. Schizophrenia Research. 255: 69-78. PMID 36965362 DOI: 10.1016/j.schres.2023.03.030 |
0.341 |
|
| 2022 |
Schutt RK, Xi H, Mueser KT, Killam MA, Delman J, Eack SM, Mesholam-Gately R, Pratt SI, Sandoval L, Santos MM, Golden LR, Keshavan MS. Cognitive Enhancement Therapy vs social skills training in schizophrenia: a cluster randomized comparative effectiveness evaluation. Bmc Psychiatry. 22: 583. PMID 36050663 DOI: 10.1186/s12888-022-04149-x |
0.306 |
|
| 2022 |
Seitz-Holland J, Wojcik JD, Cetin-Karayumak S, Lyall AE, Pasternak O, Rathi Y, Vangel M, Pearlson G, Tamminga C, Sweeney JA, Clementz BA, Schretlen DA, Viher PV, Stegmayer K, Walther S, ... ... Keshavan MS, et al. Cognitive deficits, clinical variables, and white matter microstructure in schizophrenia: a multisite harmonization study. Molecular Psychiatry. PMID 35982257 DOI: 10.1038/s41380-022-01731-3 |
0.385 |
|
| 2022 |
Karpouzian-Rogers T, Sweeney JA, Rubin LH, McDowell J, Clementz BA, Gershon E, Keshavan MS, Pearlson GD, Tamminga CA, Reilly JL. Reduced task-evoked pupillary response in preparation for an executive cognitive control response among individuals across the psychosis spectrum. Schizophrenia Research. 248: 79-88. PMID 35963057 DOI: 10.1016/j.schres.2022.07.018 |
0.31 |
|
| 2022 |
Türközer HB, Lizano P, Adhan I, Ivleva EI, Lutz O, Zeng V, Zeng A, Raymond N, Bannai D, Lee A, Bishop JR, Clementz BA, Pearlson GD, Sweeney JA, Gershon ES, ... Keshavan MS, et al. Regional and Sex-Specific Alterations in the Visual Cortex of Individuals With Psychosis Spectrum Disorders. Biological Psychiatry. PMID 35688762 DOI: 10.1016/j.biopsych.2022.03.023 |
0.781 |
|
| 2022 |
Flores AT, Hogarty SS, Mesholam-Gately RI, Barrio C, Keshavan MS, Eack SM. Cognitive gains as a mechanism of functional capacity improvement in schizophrenia: Results from a multi-site randomized controlled trial. Journal of Psychiatric Research. 151: 554-560. PMID 35636031 DOI: 10.1016/j.jpsychires.2022.05.016 |
0.326 |
|
| 2022 |
Zhao Q, Cao H, Zhang W, Li S, Xiao Y, Tamminga CA, Keshavan MS, Pearlson GD, Clementz BA, Gershon ES, Hill SK, Keedy SK, Ivleva EI, Lencer R, Sweeney JA, et al. A subtype of institutionalized patients with schizophrenia characterized by pronounced subcortical and cognitive deficits. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 35260788 DOI: 10.1038/s41386-022-01300-w |
0.331 |
|
| 2022 |
Tandon R, Keshavan M, Nasrallah H. Reinventing schizophrenia. Updating the construct. Schizophrenia Research. 242: 1-3. PMID 35241314 DOI: 10.1016/j.schres.2022.02.024 |
0.303 |
|
| 2022 |
van Gool KCA, Collin G, Bauer CCC, Molokotos E, Mesholam-Gately RI, Thermenos HW, Seidman LJ, Gabrieli JDE, Whitfield-Gabrieli S, Keshavan MS. Altered working memory-related brain activity in children at familial high risk for psychosis: A preliminary study. Schizophrenia Research. 240: 186-192. PMID 35032903 DOI: 10.1016/j.schres.2021.12.030 |
0.319 |
|
| 2021 |
Hoang D, Xu Y, Lutz O, Bannai D, Zeng V, Bishop JR, Keshavan M, Lizano P. Inflammatory Subtypes in Antipsychotic-Naïve First-Episode Schizophrenia are Associated with Altered Brain Morphology and Topological Organization. Brain, Behavior, and Immunity. 100: 297-308. PMID 34875344 DOI: 10.1016/j.bbi.2021.11.019 |
0.77 |
|
| 2021 |
Mesholam-Gately RI, Varca N, Spitzer C, Parrish EM, Hogan V, Behnke SH, Larson L, Rosa-Baez C, Schwirian N, Stromeyer C, Williams MJ, Saks ER, Keshavan MS. Are we ready for a name change for schizophrenia? A survey of multiple stakeholders. Schizophrenia Research. 238: 152-160. PMID 34688117 DOI: 10.1016/j.schres.2021.08.034 |
0.328 |
|
| 2021 |
Xiao Y, Liao W, Long Z, Tao B, Zhao Q, Luo C, Tamminga CA, Keshavan MS, Pearlson GD, Clementz BA, Gershon ES, Ivleva EI, Keedy SK, Biswal BB, Mechelli A, et al. Subtyping Schizophrenia Patients Based on Patterns of Structural Brain Alterations. Schizophrenia Bulletin. PMID 34508358 DOI: 10.1093/schbul/sbab110 |
0.37 |
|
| 2021 |
Parker DA, Trotti RL, McDowell JE, Keedy SK, Hill SK, Gershon ES, Ivleva EI, Pearlson GD, Keshavan MS, Tamminga CA, Clementz BA. Auditory Oddball Responses Across the Schizophrenia-Bipolar Spectrum and Their Relationship to Cognitive and Clinical Features. The American Journal of Psychiatry. appiajp202120071043. PMID 34407624 DOI: 10.1176/appi.ajp.2021.20071043 |
0.374 |
|
| 2021 |
Eskridge CLM, Hochberger WC, Kaseda ET, Lencer R, Reilly JL, Keedy SK, Keefe RSE, Pearlson GD, Keshavan MS, Tamminga CA, Sweeney JA, Hill SK. Deficits in generalized cognitive ability, visual sensorimotor function, and inhibitory control represent discrete domains of neurobehavioral deficit in psychotic disorders. Schizophrenia Research. 236: 54-60. PMID 34392106 DOI: 10.1016/j.schres.2021.07.036 |
0.334 |
|
| 2021 |
Grover S, Keshavan MS, Lizano PL, Reinhart RMG. Proximate markers of cognitive dysfunction in schizophrenia. Schizophrenia Research. PMID 34325964 DOI: 10.1016/j.schres.2021.07.019 |
0.345 |
|
| 2021 |
Gershon ES, Lee SH, Zhou X, Sweeney JA, Tamminga C, Pearlson GA, Clementz BA, Keshavan MS, Alliey-Rodriguez N, Hudgens-Haney M, Keedy SK, Glahn DC, Asif H, Lencer R, Hill SK. An opportunity for primary prevention research in psychotic disorders. Schizophrenia Research. PMID 34315649 DOI: 10.1016/j.schres.2021.07.001 |
0.318 |
|
| 2021 |
Eum S, Hill SK, Alliey-Rodriguez N, Stevenson JM, Rubin LH, Lee AM, Mills LJ, Reilly JL, Lencer R, Keedy SK, Ivleva E, Keefe RSE, Pearlson GD, Clementz BA, Tamminga CA, ... Keshavan MS, et al. Genome-wide association study accounting for anticholinergic burden to examine cognitive dysfunction in psychotic disorders. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 34145405 DOI: 10.1038/s41386-021-01057-8 |
0.337 |
|
| 2021 |
Merritt K, McGuire PK, Egerton A, Aleman A, Block W, Bloemen OJN, Borgan F, Bustillo JR, Capizzano AA, Coughlin JM, De la Fuente-Sandoval C, Demjaha A, Dempster K, Do KQ, ... ... Keshavan M, et al. Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level: A Mega-analysis of Individual Participant-Level Data. Jama Psychiatry. PMID 33881460 DOI: 10.1001/jamapsychiatry.2021.0380 |
0.31 |
|
| 2021 |
Deng F, Phillips MR, Cai B, Yu G, Qian M, Grivel MMR, Chen H, Ouyang X, Xue F, Zhao M, Kegeles LS, Susser ES, Keshavan MS, Stone WS, Yang LH. Comparison of social cognition using an adapted Chinese version of the Reading the Mind in the Eyes Test in drug-naive and regularly medicated individuals with chronic schizophrenia and healthy controls in rural China. Psychological Medicine. 1-13. PMID 33722309 DOI: 10.1017/S003329172100043X |
0.314 |
|
| 2021 |
Türközer HB, Ivleva EI, Palka J, Clementz BA, Shafee R, Pearlson GD, Sweeney JA, Keshavan MS, Gershon ES, Tamminga CA. Biomarker Profiles in Psychosis Risk Groups Within Unaffected Relatives Based on Familiality and Age. Schizophrenia Bulletin. PMID 33693883 DOI: 10.1093/schbul/sbab013 |
0.31 |
|
| 2021 |
Trotti RL, Abdelmageed S, Parker DA, Sabatinelli D, Tamminga CA, Gershon ES, Keedy SK, Keshavan MS, Pearlson GD, Sweeney JA, McDowell JE, Clementz BA. Neural Processing of Repeated Emotional Scenes in Schizophrenia, Schizoaffective Disorder, and Bipolar Disorder. Schizophrenia Bulletin. PMID 33693875 DOI: 10.1093/schbul/sbab018 |
0.377 |
|
| 2021 |
Huang LY, Jackson BS, Rodrigue AL, Tamminga CA, Gershon ES, Pearlson GD, Keshavan MS, Keedy SS, Hill SK, Sweeney JA, Clementz BA, McDowell JE. Antisaccade error rates and gap effects in psychosis syndromes from bipolar-schizophrenia network for intermediate phenotypes 2 (B-SNIP2). Psychological Medicine. 1-10. PMID 33622437 DOI: 10.1017/S003329172000478X |
0.38 |
|
| 2021 |
Hegde RR, Guimond S, Bannai D, Zeng V, Padani S, Eack SM, Keshavan MS. Theory of Mind impairments in early course schizophrenia: An fMRI study. Journal of Psychiatric Research. 136: 236-243. PMID 33621908 DOI: 10.1016/j.jpsychires.2021.02.010 |
0.324 |
|
| 2021 |
Hoang D, Lizano P, Lutz O, Zeng V, Raymond N, Miewald J, Montrose D, Keshavan M. Thalamic, Amygdalar, and hippocampal nuclei morphology and their trajectories in first episode psychosis: A preliminary longitudinal study. Psychiatry Research. Neuroimaging. 309: 111249. PMID 33484937 DOI: 10.1016/j.pscychresns.2021.111249 |
0.78 |
|
| 2021 |
Seitz-Holland J, Cetin-Karayumak S, Wojcik JD, Lyall A, Levitt J, Shenton ME, Pasternak O, Westin CF, Baxi M, Kelly S, Mesholam-Gately R, Vangel M, Pearlson G, Tamminga CA, Sweeney JA, ... ... Keshavan M, et al. Elucidating the relationship between white matter structure, demographic, and clinical variables in schizophrenia-a multicenter harmonized diffusion tensor imaging study. Molecular Psychiatry. PMID 33483689 DOI: 10.1038/s41380-021-01018-z |
0.339 |
|
| 2021 |
Seccomandi B, Agbedjro D, Bell M, Keefe RSE, Keshavan M, Galderisi S, Fiszdon J, Mucci A, Cavallaro R, Ojeda N, Peña J, Müller D, Roder V, Wykes T, Cella M. Exploring the role of age as a moderator of cognitive remediation for people with schizophrenia. Schizophrenia Research. 228: 29-35. PMID 33429151 DOI: 10.1016/j.schres.2020.11.060 |
0.323 |
|
| 2021 |
Seitz-Holland J, Wojcik JD, Cetin-Karayumak S, Lyall A, Pasternak O, Rathi Y, Pearlson G, Tamminga C, Sweeney J, Clementz B, Schretlen D, Viher PV, Stegmayer K, Walther S, Lee J, ... ... Keshavan M, et al. Cognitive Deficits and Their White Matter Correlates in Schizophrenia Biological Psychiatry. 89: S368. DOI: 10.1016/j.biopsych.2021.02.916 |
0.349 |
|
| 2021 |
Kuo SS, Lee J, Horan W, Subotnik K, Ventura J, Keshavan M, Green MF, Nuechterlein K, Eack S. Cognitive and Emotion Processing Profiles in Adult Neurodevelopmental Disorders: Identifying Transdiagnostic Subgroups Across Autism Spectrum Disorder, Schizophrenia, and Neurotypical Development Biological Psychiatry. 89: S215-S216. DOI: 10.1016/j.biopsych.2021.02.545 |
0.34 |
|
| 2021 |
Hegde R, Lizano P, Kelly S, Lutz O, Karayumak SC, Pasternak O, Kubicki M, Eack S, Keshavan M. Cognitive Enhancement Therapy Might Halt Progressive White Matter Microstructural Changes in Early Course Schizophrenia Biological Psychiatry. 89: S211. DOI: 10.1016/j.biopsych.2021.02.534 |
0.318 |
|
| 2020 |
Parker DA, Trotti RL, McDowell JE, Keedy SK, Gershon ES, Ivleva EI, Pearlson GD, Keshavan MS, Tamminga CA, Sweeney JA, Clementz BA. Auditory paired-stimuli responses across the psychosis and bipolar spectrum and their relationship to clinical features. Biomarkers in Neuropsychiatry. 3. PMID 36644018 DOI: 10.1016/j.bionps.2020.100014 |
0.35 |
|
| 2020 |
Kelly S, Guimond S, Pasternak O, Lutz O, Lizano P, Cetin-Karayumak S, Sweeney JA, Pearlson G, Clementz BA, McDowell JE, Tamminga CA, Shenton ME, Keshavan MS. White matter microstructure across brain-based biotypes for psychosis - findings from the bipolar-schizophrenia network for intermediate phenotypes. Psychiatry Research. Neuroimaging. 308: 111234. PMID 33385763 DOI: 10.1016/j.pscychresns.2020.111234 |
0.782 |
|
| 2020 |
Seccomandi B, Agbedjro D, Bell M, Keefe RSE, Keshavan M, Galderisi S, Fiszdon J, Mucci A, Cavallaro R, Bechi M, Ojeda N, Peña J, Wykes T, Cella M. Can IQ moderate the response to cognitive remediation in people with schizophrenia? Journal of Psychiatric Research. 133: 38-45. PMID 33307353 DOI: 10.1016/j.jpsychires.2020.12.013 |
0.307 |
|
| 2020 |
Guimond S, Ling G, Drodge J, Matheson H, Wojtalik JA, Lopez B, Collin G, Brady R, Mesholam-Gately RI, Thermenos H, Eack SM, Keshavan MS. Functional connectivity associated with improvement in emotion management after cognitive enhancement therapy in early-course schizophrenia. Psychological Medicine. 1-10. PMID 33183362 DOI: 10.1017/S0033291720004110 |
0.791 |
|
| 2020 |
Lizano P, Lutz O, Xu Y, Rubin LH, Paskowitz L, Lee AM, Eum S, Keedy SK, Hill SK, Reilly JL, Wu B, Tamminga CA, Clementz BA, Pearlson GD, Gershon ES, ... Keshavan MS, et al. Multivariate relationships between peripheral inflammatory marker subtypes and cognitive and brain structural measures in psychosis. Molecular Psychiatry. PMID 33060818 DOI: 10.1038/s41380-020-00914-0 |
0.777 |
|
| 2020 |
Calkins ME, Woods SW, Bearden CE, Liu L, Moore TM, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Mathalon DH, Keshavan M, et al. Concordance and factor structure of subthreshold positive symptoms in youth at clinical high risk for psychosis. Schizophrenia Research. PMID 32943313 DOI: 10.1016/J.Schres.2020.08.014 |
0.332 |
|
| 2020 |
Del Re EC, Stone WS, Bouix S, Seitz J, Zeng V, Guliano A, Somes N, Zhang T, Reid B, Lyall A, Lyons M, Li H, Whitfield-Gabrieli S, Keshavan M, Seidman LJ, et al. Baseline Cortical Thickness Reductions in Clinical High Risk for Psychosis: Brain Regions Associated with Conversion to Psychosis Versus Non-Conversion as Assessed at One-Year Follow-Up in the Shanghai-At-Risk-for-Psychosis (SHARP) Study. Schizophrenia Bulletin. PMID 32926141 DOI: 10.1093/Schbul/Sbaa127 |
0.374 |
|
| 2020 |
Hegde RR, Kelly S, Lutz O, Guimond S, Karayumak SC, Mike L, Mesholam-Gately RI, Pasternak O, Kubicki M, Eack SM, Keshavan MS. Association of white matter microstructure and extracellular free-water with cognitive performance in the early course of schizophrenia. Psychiatry Research. Neuroimaging. 305: 111159. PMID 32919288 DOI: 10.1016/J.Pscychresns.2020.111159 |
0.778 |
|
| 2020 |
Henson P, Pearson JF, Keshavan M, Torous J. Impact of dynamic greenspace exposure on symptomatology in individuals with schizophrenia. Plos One. 15: e0238498. PMID 32881899 DOI: 10.1371/Journal.Pone.0238498 |
0.367 |
|
| 2020 |
Seitz J, Cetin-Karayumak S, Lyall A, Pasternak O, Baxi M, Vangel M, Pearlson G, Tamminga C, Sweeney J, Clementz B, Schretlen D, Viher PV, Stegmayer K, Walther S, Lee J, ... ... Keshavan M, et al. Investigating Sexual Dimorphism of Human White Matter in a Harmonized, Multisite Diffusion Magnetic Resonance Imaging Study. Cerebral Cortex (New York, N.Y. : 1991). PMID 32851404 DOI: 10.1093/Cercor/Bhaa220 |
0.311 |
|
| 2020 |
Hochberger WC, Eskridge CLM, Bishop JR, Reilly JL, Rubin LH, Keedy S, Gershon ES, Tamminga CA, Pearlson GD, Ragozzino M, Keshavan MS, Sweeney JA, Hill SK. Catechol-O-methyltransferase genotype differentially contributes to the flexibility and stability of cognitive sets in patients with psychotic disorders and their first-degree relatives. Schizophrenia Research. PMID 32829984 DOI: 10.1016/J.Schres.2020.08.005 |
0.322 |
|
| 2020 |
Gotra MY, Hill SK, Gershon ES, Tamminga CA, Ivleva EI, Pearlson GD, Keshavan MS, Clementz BA, McDowell JE, Buckley PF, Sweeney JA, Keedy SK. Distinguishing patterns of impairment on inhibitory control and general cognitive ability among bipolar with and without psychosis, schizophrenia, and schizoaffective disorder. Schizophrenia Research. PMID 32674921 DOI: 10.1016/J.Schres.2020.06.033 |
0.398 |
|
| 2020 |
Nawaz U, Lee I, Beermann A, Eack S, Keshavan M, Brady R. Individual Variation in Functional Brain Network Topography is Linked to Schizophrenia Symptomatology. Schizophrenia Bulletin. PMID 32648915 DOI: 10.1093/Schbul/Sbaa088 |
0.395 |
|
| 2020 |
Stone WS, Cai B, Liu X, Grivel MM, Yu G, Xu Y, Ouyang X, Chen H, Deng F, Xue F, Li H, Lieberman JA, Keshavan MS, Susser ES, Yang LH, et al. Association Between the Duration of Untreated Psychosis and Selective Cognitive Performance in Community-Dwelling Individuals With Chronic Untreated Schizophrenia in Rural China. Jama Psychiatry. PMID 32639517 DOI: 10.1001/Jamapsychiatry.2020.1619 |
0.346 |
|
| 2020 |
Zeng V, Lizano P, Bolo NR, Lutz O, Brady R, Ivleva EI, Dai W, Clementz B, Tamminga C, Pearlson G, Keshavan M. Altered Cerebral Perfusion in Bipolar Disorder: A pCASL MRI Study. Bipolar Disorders. PMID 32583570 DOI: 10.1111/Bdi.12966 |
0.785 |
|
| 2020 |
Lutz O, Lizano P, Mothi SS, Zeng V, Hegde RR, Hoang DT, Henson P, Brady R, Tamminga CA, Pearlson G, Clementz BA, Sweeney JA, Keshavan MS. Do neurobiological differences exist between paranoid and non-paranoid schizophrenia? Findings from the bipolar schizophrenia network on intermediate phenotypes study. Schizophrenia Research. PMID 32507376 DOI: 10.1016/J.Schres.2020.02.011 |
0.767 |
|
| 2020 |
Henson P, Barnett I, Keshavan M, Torous J. Towards clinically actionable digital phenotyping targets in schizophrenia. Npj Schizophrenia. 6: 13. PMID 32372059 DOI: 10.1038/s41537-020-0100-1 |
0.3 |
|
| 2020 |
Adhan I, Lizano P, Bannai D, Lutz O, Dhaliwal K, Zeng V, Miewald J, Montrose D, Keshavan M. Visual Cortical Alterations and their Association with Negative Symptoms in Antipsychotic-Naïve First Episode Psychosis. Psychiatry Research. 288: 112957. PMID 32325384 DOI: 10.1016/J.Psychres.2020.112957 |
0.754 |
|
| 2020 |
Bannai D, Lizano P, Kasetty M, Lutz O, Zeng V, Sarvode S, Kim LA, Hill S, Tamminga C, Clementz B, Gershon E, Pearlson G, Miller JB, Keshavan M. Retinal layer abnormalities and their association with clinical and brain measures in psychotic disorders: A preliminary study. Psychiatry Research. Neuroimaging. 299: 111061. PMID 32145500 DOI: 10.1016/J.Pscychresns.2020.111061 |
0.75 |
|
| 2020 |
Keshavan MS, Kelly S, Hall MH. The Core Deficit of "Classical" Schizophrenia Cuts Across the Psychosis Spectrum. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 706743719898911. PMID 31961197 DOI: 10.1177/0706743719898911 |
0.326 |
|
| 2020 |
Velikonja T, Velthorst E, Zinberg J, Cannon TD, Cornblatt BA, Perkins DO, Cadenhead KS, Tsuang MT, Addington J, Woods SW, McGlashan T, Mathalon DH, Stone W, Keshavan M, Seidman L, et al. Childhood trauma and cognitive functioning in individuals at clinical high risk (CHR) for psychosis. Development and Psychopathology. 1-12. PMID 31959269 DOI: 10.1017/S095457941900155X |
0.34 |
|
| 2020 |
Keshavan M, Lizano P, Prasad K. The synaptic pruning hypothesis of schizophrenia: promises and challenges. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 19: 110-111. PMID 31922664 DOI: 10.1002/Wps.20725 |
0.387 |
|
| 2020 |
Keshavan MS, Collin G, Guimond S, Kelly S, Prasad KM, Lizano P. Neuroimaging in Schizophrenia. Neuroimaging Clinics of North America. 30: 73-83. PMID 31759574 DOI: 10.1016/j.nic.2019.09.007 |
0.364 |
|
| 2020 |
Lizano P, Dhaliwal K, Lutz O, Mothi SS, Miewald J, Montrose D, Keshavan M. Trajectory of neurological examination abnormalities in antipsychotic-naïve first-episode psychosis population: a 1 year follow-up study. Psychological Medicine. 50: 2057-2065. PMID 31451118 DOI: 10.1017/S0033291719002162 |
0.748 |
|
| 2020 |
Seitz J, Cetin Karayumak S, Wojcik J, Lyall A, Levitt J, Pasternak O, Baxi M, Kelly S, Sweeney J, Viher P, Stegmayer K, Walther S, Lee J, Crow TJ, James A, ... ... Keshavan M, et al. S157. A MULTICENTER HARMONIZED DIFFUSION TENSOR IMAGING STUDY ON THE ASSOCIATION OF WHITE MATTER STRUCTURE AND CLINICAL FUNCTIONING Schizophrenia Bulletin. 46: S95-S96. DOI: 10.1093/Schbul/Sbaa031.223 |
0.393 |
|
| 2020 |
Torous J, Wisniewski H, Camacho E, Henson P, Rodriguez-Villa E, Hays R, Lagan S, Vaidyam A, Keshavan M. T98. Characterizing The Clinical Course In Schizophrenia With Digital Phenotyping Schizophrenia Bulletin. 46. DOI: 10.1093/Schbul/Sbaa029.658 |
0.39 |
|
| 2020 |
del Re EC, Zeng V, Lutz O, Pearlson G, Sweeney J, Clementz B, Gershon ES, Keedy S, Ivleva E, Tamminga C, Keshavan M. O10.6. ANTERIOR VERSUS POSTERIOR HIPPOCAMPUS WITHIN PSYCHOSIS: A BSNIP STUDY Schizophrenia Bulletin. 46: S26-S27. DOI: 10.1093/Schbul/Sbaa028.060 |
0.421 |
|
| 2020 |
Clementz B, Trotti R, Pearlson GD, Keshavan M, Gershon E, Keedy S, Ivleva E, McDowell JE, Tamminga C. O3.4. PSYCHOSIS PHENOTYPES FROM B-SNIP FOR CLINICAL ADVANCES: BIOTYPE CHARACTERISTICS AND TARGETS Schizophrenia Bulletin. 46: S7-S7. DOI: 10.1093/Schbul/Sbaa028.015 |
0.392 |
|
| 2020 |
Okuneye V, Clementz B, Gershon E, Keshavan M, McDowell JE, Pearlson G, Tamminga C, Sweeney J, Keedy S. O2.6. DELUSIONS ASSOCIATED WITH ABNORMAL FRONTOSTRIATAL EFFECTIVE CONNECTIVITY IN A SPECTRAL DCM ANALYSIS OF RESTING STATE FMRI Schizophrenia Bulletin. 46: S5-S5. DOI: 10.1093/Schbul/Sbaa028.011 |
0.339 |
|
| 2020 |
Zeng V, Lizano P, Hegde R, Lutz O, Hoang D, Adhan I, Nisenson M, Raymond N, Lai M, Bannai D, Tamminga C, Clementz B, Pearlson G, Sweeney J, Keshavan M. Thalamic Nuclei Reductions Across the Psychosis Spectrum: A BSNIP Study Biological Psychiatry. 87. DOI: 10.1016/J.Biopsych.2020.02.881 |
0.311 |
|
| 2020 |
Bannai D, Adhan I, Douglas KA, Kasetty M, Lutz O, Keshavan M, Miller J, Lizano P. Shedding Light on Pathophysiologic Mechanisms in Schizophrenia and Bipolar Disorder Through Analysis of Retinal Structural-Vascular-Functional Relationships Biological Psychiatry. 87. DOI: 10.1016/J.Biopsych.2020.02.869 |
0.406 |
|
| 2020 |
Lai M, Kelly S, Hegde R, Bannai D, Lizano P, Keshavan M. Investigating Sleep Spindle Density and Schizophrenia: A Meta-Analysis Biological Psychiatry. 87. DOI: 10.1016/J.Biopsych.2020.02.771 |
0.337 |
|
| 2020 |
Douglas KA, Bannai D, Adhan I, Kasetty M, Miller JB, Keshavan M, Lizano P. A Preliminary Study Using OCT-A to Determine Deep Layer Retinal Vascular Changes in Schizophrenia Biological Psychiatry. 87. DOI: 10.1016/J.Biopsych.2020.02.633 |
0.352 |
|
| 2020 |
Adhan I, Lizano P, Bannai D, Kassety M, Miller J, Keshavan M. A Pilot Study of Retinal RNFL, GCL, and Choroidal Layer in Schizophrenia Using Swept Source Optical Tomography Coherence Imaging Biological Psychiatry. 87. DOI: 10.1016/J.Biopsych.2020.02.631 |
0.329 |
|
| 2020 |
Turkozer HB, Lizano P, Adhan I, Ivleva EI, Lutz O, Zeng A, Raymond N, Clementz BA, Pearlson G, Sweeney J, Gershon E, Keshavan M, Tamminga C. Neuroanatomical Sex Differences in the Visual Cortex of Individuals With Psychosis: Findings From the Bipolar-Schizophrenia Network on Intermediate Phenotypes Biological Psychiatry. 87: S205. DOI: 10.1016/J.Biopsych.2020.02.533 |
0.424 |
|
| 2020 |
Raymond N, Hegde R, Kelly S, Zeng V, Lutz O, Karayumak SC, Pasternak O, Kubicki M, Eack S, Keshavan M. White Matter Microstructure and Emotion Recognition in Early Course Schizophrenia Biological Psychiatry. 87. DOI: 10.1016/J.Biopsych.2020.02.1199 |
0.398 |
|
| 2020 |
Lizano P, Bannai D, Adhan I, Douglas KA, Kasetty M, Keshavan M, Miller JB. Superficial Retinal Vascular Abnormalities in Schizophrenia as Shown by Swept Source OCT-Angiography: A Preliminary Study Biological Psychiatry. 87. DOI: 10.1016/J.Biopsych.2020.02.1133 |
0.377 |
|
| 2020 |
Trotti R, Parker D, Tamminga C, Pearlson G, Keshavan M, Keedy S, Gershon E, McDowell JE, Clementz B. Longitudinal Stability of EEG Psychosis Biomarkers: Findings From the Bipolar-Schizophrenia Network for Intermediate Phenotypes (B-SNIP) Biological Psychiatry. 87: S409-S410. DOI: 10.1016/J.Biopsych.2020.02.1045 |
0.41 |
|
| 2020 |
Brady R, Beermann A, Nawaz U, Keshavan M, Ongur D, Halko M, Lewandowski KE. Cerebellar-Cortical Disconnectivity Causes Cognitive Dysfunction in Psychotic Disorders Biological Psychiatry. 87: S11. DOI: 10.1016/J.Biopsych.2020.02.055 |
0.399 |
|
| 2019 |
Zhang W, Du L, Keedy SK, Ivleva EI, Eum S, Yao L, Tamminga CA, Clementz BA, Keshavan MS, Pearlson GD, Gershon ES, Bishop JR, Gong Q, Lui S, Sweeney JA. Brain gray matter network organization in psychotic disorders. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 31812151 DOI: 10.1038/S41386-019-0586-2 |
0.366 |
|
| 2019 |
Massa N, Owens AV, Harmon W, Bhattacharya A, Ivleva EI, Keedy S, Sweeney JA, Pearlson GD, Keshavan MS, Tamminga CA, Clementz BA, Duncan E. Relationship of prolonged acoustic startle latency to diagnosis and biotype in the bipolar-schizophrenia network on intermediate phenotypes (B-SNIP) cohort. Schizophrenia Research. PMID 31796306 DOI: 10.1016/J.Schres.2019.11.013 |
0.356 |
|
| 2019 |
Brakemeier S, Sprenger A, Meyhöfer I, McDowell JE, Rubin LH, Hill SK, Keshavan MS, Pearlson GD, Tamminga CA, Gershon ES, Keedy SS, Sweeney JA, Clementz BA, Lencer R. Smooth pursuit eye movement deficits as a biomarker for psychotic features in bipolar disorder - Findings from the PARDIP study. Bipolar Disorders. PMID 31721386 DOI: 10.1111/Bdi.12865 |
0.303 |
|
| 2019 |
Alliey-Rodriguez N, Grey TA, Shafee R, Asif H, Lutz O, Bolo NR, Padmanabhan J, Tandon N, Klinger M, Reis K, Spring J, Coppes L, Zeng V, Hegde RR, Hoang DT, ... ... Keshavan MS, et al. NRXN1 is associated with enlargement of the temporal horns of the lateral ventricles in psychosis. Translational Psychiatry. 9: 230. PMID 31530798 DOI: 10.1038/S41398-019-0564-9 |
0.758 |
|
| 2019 |
Cetin-Karayumak S, Di Biase MA, Chunga N, Reid B, Somes N, Lyall AE, Kelly S, Solgun B, Pasternak O, Vangel M, Pearlson G, Tamminga C, Sweeney JA, Clementz B, Schretlen D, ... ... Keshavan M, et al. White matter abnormalities across the lifespan of schizophrenia: a harmonized multi-site diffusion MRI study. Molecular Psychiatry. PMID 31511636 DOI: 10.1038/S41380-019-0509-Y |
0.416 |
|
| 2019 |
Kuo SS, Wojtalik JA, Mesholam-Gately RI, Keshavan MS, Eack SM. Transdiagnostic validity of the MATRICS Consensus Cognitive Battery across the autism-schizophrenia spectrum. Psychological Medicine. 1-10. PMID 31298174 DOI: 10.1017/S0033291719001582 |
0.383 |
|
| 2019 |
Lizano P, Lutz O, Ling G, Lee AM, Eum S, Bishop JR, Kelly S, Pasternak O, Clementz B, Pearlson G, Sweeney JA, Gershon E, Tamminga C, Keshavan M. Association of Choroid Plexus Enlargement With Cognitive, Inflammatory, and Structural Phenotypes Across the Psychosis Spectrum. The American Journal of Psychiatry. appiajp201918070825. PMID 31164007 DOI: 10.1176/Appi.Ajp.2019.18070825 |
0.78 |
|
| 2019 |
Kuo SS, Wojtalik JA, Mesholam-Gately RI, Keshavan MS, Eack SM. Establishing a standard emotion processing battery for treatment evaluation in adults with autism spectrum disorder: Evidence supporting the Mayer-Salovey-Caruso Emotion Intelligence Test (MSCEIT). Psychiatry Research. 278: 116-124. PMID 31163301 DOI: 10.1016/J.Psychres.2019.05.011 |
0.314 |
|
| 2019 |
Ji JL, Diehl C, Schleifer C, Tamminga CA, Keshavan MS, Sweeney JA, Clementz BA, Hill SK, Pearlson G, Yang G, Creatura G, Krystal JH, Repovs G, Murray J, Winkler A, et al. Schizophrenia Exhibits Bi-directional Brain-Wide Alterations in Cortico-Striato-Cerebellar Circuits. Cerebral Cortex (New York, N.Y. : 1991). PMID 31157363 DOI: 10.1093/Cercor/Bhy306 |
0.305 |
|
| 2019 |
Lizano P, Bannai D, Lutz O, Kim LA, Miller J, Keshavan M. A Meta-analysis of Retinal Cytoarchitectural Abnormalities in Schizophrenia and Bipolar Disorder. Schizophrenia Bulletin. PMID 31112601 DOI: 10.1093/Schbul/Sbz029 |
0.783 |
|
| 2019 |
Guimond S, Keshavan MS, Torous JB. Towards remote digital phenotyping of cognition in schizophrenia. Schizophrenia Research. 208: 36-38. PMID 31047724 DOI: 10.1016/j.schres.2019.04.016 |
0.34 |
|
| 2019 |
Liu G, Henson P, Keshavan M, Pekka-Onnela J, Torous J. Assessing the potential of longitudinal smartphone based cognitive assessment in schizophrenia: A naturalistic pilot study. Schizophrenia Research. Cognition. 17: 100144. PMID 31024801 DOI: 10.1016/J.Scog.2019.100144 |
0.423 |
|
| 2019 |
Mike L, Guimond S, Kelly S, Thermenos H, Mesholam-Gately R, Eack S, Keshavan M. Social cognition in early course of schizophrenia: Exploratory factor analysis. Psychiatry Research. 272: 737-743. PMID 30832194 DOI: 10.1016/J.Psychres.2018.12.152 |
0.412 |
|
| 2019 |
Foss-Feig JH, Velthorst E, Smith L, Reichenberg A, Addington J, Cadenhead KS, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Stone WS, Keshavan M, Tsuang MT, Walker EF, et al. Clinical Profiles and Conversion Rates Among Young Individuals With Autism Spectrum Disorder Who Present to Clinical High Risk For Psychosis Services. Journal of the American Academy of Child and Adolescent Psychiatry. PMID 30797038 DOI: 10.1016/J.Jaac.2018.09.446 |
0.394 |
|
| 2019 |
Lutz O, Lizano P, Mothi SS, Joseph A, Tandon N, Ormston L, Hooper S, Keshavan M, Shashi V. Hypogyrification and its association with cognitive impairment in children with 22q11.2 deletion Syndrome: A preliminary report. Psychiatry Research. Neuroimaging. 285: 47-50. PMID 30743074 DOI: 10.1016/J.Pscychresns.2019.01.007 |
0.775 |
|
| 2019 |
Brady RO, Gonsalvez I, Lee I, Öngür D, Seidman LJ, Schmahmann JD, Eack SM, Keshavan MS, Pascual-Leone A, Halko MA. Cerebellar-Prefrontal Network Connectivity and Negative Symptoms in Schizophrenia. The American Journal of Psychiatry. appiajp201818040429. PMID 30696271 DOI: 10.1176/Appi.Ajp.2018.18040429 |
0.325 |
|
| 2019 |
Ling G, Lee I, Guimond S, Lutz O, Tandon N, Nawaz U, Öngür D, Eack S, Lewandowski K, Keshavan M, Brady R. Individual variation in brain network topology is linked to emotional intelligence. Neuroimage. PMID 30630078 DOI: 10.1016/J.Neuroimage.2019.01.013 |
0.757 |
|
| 2019 |
Reininghaus U, Böhnke JR, Chavez-Baldini U, Gibbons R, Ivleva E, Clementz BA, Pearlson GD, Keshavan MS, Sweeney JA, Tamminga CA. Transdiagnostic dimensions of psychosis in the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP). World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 18: 67-76. PMID 30600629 DOI: 10.1002/Wps.20607 |
0.319 |
|
| 2019 |
Torous J, Wisniewski H, Keshavan M, Liu G, Barnett I. 29.2 Digital Phenotyping Of Micro-Cognitive Measures (Mcm) In Patients With Schizophrenia Schizophrenia Bulletin. 45. DOI: 10.1093/Schbul/Sbz022.118 |
0.45 |
|
| 2019 |
Kelly S, Guimond S, Pasternak O, Lutz O, Sweeney JA, Pearlson G, Clementz B, Tamminga C, Shenton ME, Keshavan M. O11.4. DIAGNOSIS AND BIOTYPE COMPARISON ACROSS THE PSYCHOSIS SPECTRUM: INVESTIGATING WHITE MATTER MICROSTRUCTURAL DIFFERENCES FROM THE BIPOLAR-SCHIZOPHRENIA NETWORK ON INTERMEDIATE PHENOTYPES (B-SNIP) STUDY USING FREE-WATER IMAGING Schizophrenia Bulletin. 45: S195-S195. DOI: 10.1093/Schbul/Sbz021.260 |
0.4 |
|
| 2019 |
Trotti R, Parker D, Sabatinelli D, Tamminga C, Gershon E, Keedy S, Sweeney J, Keshavan M, Pearlson G, McDowell JE, Clementz B. O9.5. EMOTIONAL SCENE PROCESSING IN PSYCHOSIS BIOTYPES: FINDINGS FROM THE BIPOLAR-SCHIZOPHRENIA NETWORK ON INTERMEDIATE PHENOTYPES (BSNIP) Schizophrenia Bulletin. 45: S188-S188. DOI: 10.1093/Schbul/Sbz021.245 |
0.391 |
|
| 2019 |
Wojtalik J, Eack S, Keshavan M. O8.3. CONFIRMATORY EFFICACY OF COGNITIVE ENHANCEMENT THERAPY FOR EARLY SCHIZOPHRENIA: RESULTS FROM A MULTI-SITE RANDOMIZED TRIAL Schizophrenia Bulletin. 45: S184-S184. DOI: 10.1093/Schbul/Sbz021.235 |
0.373 |
|
| 2019 |
Torous J, Keshavan M, Pearson J. S131. Towards Spatial Analysis Of Digital Phenotyping Smartphone Activity In Schizophrenia Schizophrenia Bulletin. 45. DOI: 10.1093/Schbul/Sbz020.676 |
0.378 |
|
| 2019 |
Guimond S, Gu F, Ormston L, Tingue S, Padani S, Sandoval L, Keshavan M. S100. COGNITIVE ENHANCEMENT THERAPY IN SCHIZOPHRENIA: A QUANTITATIVE AND QUALITATIVE ANALYSIS OF PATIENTS’ EXPERIENCES Schizophrenia Bulletin. 45: S344-S345. DOI: 10.1093/Schbul/Sbz020.645 |
0.411 |
|
| 2019 |
Alliey N, Gershon E, Grey TA, Shafee R, Tandon N, Coppes L, Keedy S, McCarroll S, Pearlson G, Keshavan M, Clementz BA, Tamminga C. COMMON VARIANTS OF NRXN1, LRP1B AND RORA ARE ASSOCIATED WITH INCREASED VENTRICULAR VOLUMES IN SCHIZOPHRENIA AND BIPOLAR DISORDER European Neuropsychopharmacology. 29: S924-S925. DOI: 10.1016/J.Euroneuro.2017.08.257 |
0.462 |
|
| 2019 |
Tang D, Theis N, Iyengar S, Keshavan M, Prasad K. S174. Longitudinal Invariance of Structural Covariance Networks in First-Episode Antipsychotic-Naïve Psychotic Disorders Biological Psychiatry. 85: S364-S365. DOI: 10.1016/J.Biopsych.2019.03.925 |
0.353 |
|
| 2019 |
Theis N, Tang D, Iyengar S, Keshavan M, Prasad K. S173. Altered Structural Covariance Networks of Cortical Gray Matter and Surface Area in First-Episode Antipsychotic-Naïve Psychotic Disorder Biological Psychiatry. 85: S364. DOI: 10.1016/J.Biopsych.2019.03.924 |
0.362 |
|
| 2019 |
Hegde R, Kelly S, Lutz O, Berman D, Yao L, Guimond S, Mike L, Thermenos H, Karayumak SC, Kubicki M, Eack S, Keshavan M. F193. White Matter Microstructure and Social Cognition in Early Course Schizophrenia Biological Psychiatry. 85: S288. DOI: 10.1016/J.Biopsych.2019.03.730 |
0.415 |
|
| 2019 |
Baran B, Denis D, Larson O, Sato E, Kohnke E, Keshavan M, Stickgold R, Manoach DS. T200. Abnormal Thalamocortical Functional Connectivity and Sensory Gating Deficits in Psychotic Disorders: Are These Two Biomarkers Related? Biological Psychiatry. 85. DOI: 10.1016/J.Biopsych.2019.03.523 |
0.354 |
|
| 2019 |
Bannai D, Lutz O, Keshavan M, Miller JB, Lizano P. T181. Retinal Cytoarchitectural Abnormalities in Schizophrenia and Bipolar Disorder: A Meta-Analysis Biological Psychiatry. 85. DOI: 10.1016/J.Biopsych.2019.03.504 |
0.427 |
|
| 2018 |
Kelly S, Guimond S, Lyall A, Stone WS, Shenton ME, Keshavan M, Seidman LJ. Neural correlates of cognitive deficits across developmental phases of schizophrenia. Neurobiology of Disease. PMID 30582983 DOI: 10.1016/J.Nbd.2018.12.013 |
0.466 |
|
| 2018 |
Rubin LH, Li S, Yao L, Keedy SK, Reilly JL, Hill SK, Bishop JR, Sue Carter C, Pournajafi-Nazarloo H, Drogos LL, Gershon E, Pearlson GD, Tamminga CA, Clementz BA, Keshavan MS, et al. Peripheral oxytocin and vasopressin modulates regional brain activity differently in men and women with schizophrenia. Schizophrenia Research. 202: 173-179. PMID 30539769 DOI: 10.1016/j.schres.2018.07.003 |
0.359 |
|
| 2018 |
Collin G, Seidman LJ, Keshavan MS, Stone WS, Qi Z, Zhang T, Tang Y, Li H, Anteraper SA, Niznikiewicz MA, McCarley RW, Shenton ME, Wang J, Whitfield-Gabrieli S. Functional connectome organization predicts conversion to psychosis in clinical high-risk youth from the SHARP program. Molecular Psychiatry. PMID 30410064 DOI: 10.1038/S41380-018-0288-X |
0.309 |
|
| 2018 |
Lee I, Nielsen K, Hall MH, Öngür D, Keshavan M, Brady JR. Diverse pathophysiological processes converge on network disruption in mania. Journal of Affective Disorders. 244: 115-123. PMID 30340100 DOI: 10.1016/J.Jad.2018.10.087 |
0.33 |
|
| 2018 |
Lizano P, Lutz O, Ling G, Padmanabhan J, Tandon N, Sweeney J, Tamminga C, Pearlson G, Ruaño G, Kocherla M, Windemuth A, Clementz B, Gershon E, Keshavan M. VEGFA GENE variation influences hallucinations and frontotemporal morphology in psychotic disorders: a B-SNIP study. Translational Psychiatry. 8: 215. PMID 30310054 DOI: 10.1038/S41398-018-0271-Y |
0.772 |
|
| 2018 |
Lencer R, Yao L, Reilly JL, Keedy SK, McDowell JE, Keshavan MS, Pearlson GD, Tamminga CA, Gershon ES, Clementz BA, Lui S, Sweeney JA. Alterations in intrinsic fronto-thalamo-parietal connectivity are associated with cognitive control deficits in psychotic disorders. Human Brain Mapping. PMID 30260540 DOI: 10.1002/Hbm.24362 |
0.304 |
|
| 2018 |
Collin G, Keshavan MS. Connectome development and a novel extension to the neurodevelopmental model of schizophrenia. Dialogues in Clinical Neuroscience. 20: 101-111. PMID 30250387 |
0.306 |
|
| 2018 |
Schreiber SR, Wojtalik JA, Walker CP, Cho RY, Eack SM, Keshavan MS. Serum anticholinergicity is associated with reduced prefrontal brain function in early course schizophrenia. Psychiatry Research. Neuroimaging. 281: 31-34. PMID 30216862 DOI: 10.1016/J.Pscychresns.2018.08.017 |
0.345 |
|
| 2018 |
Shafee R, Nanda P, Padmanabhan JL, Tandon N, Alliey-Rodriguez N, Kalapurakkel S, Weiner DJ, Gur RE, Keefe RSE, Hill SK, Bishop JR, Clementz BA, Tamminga CA, Gershon ES, Pearlson GD, ... Keshavan MS, et al. Polygenic risk for schizophrenia and measured domains of cognition in individuals with psychosis and controls. Translational Psychiatry. 8: 78. PMID 29643358 DOI: 10.1038/S41398-018-0124-8 |
0.401 |
|
| 2018 |
Abush H, Ghose S, Van Enkevort EA, Clementz BA, Pearlson GD, Sweeney JA, Keshavan MS, Tamminga CA, Ivleva EI. Associations between adolescent cannabis use and brain structure in psychosis. Psychiatry Research. PMID 29628270 DOI: 10.1016/J.Pscychresns.2018.03.008 |
0.352 |
|
| 2018 |
Guimond S, Padani S, Lutz O, Eack S, Thermenos H, Keshavan M. Impaired regulation of emotional distractors during working memory load in schizophrenia. Journal of Psychiatric Research. 101: 14-20. PMID 29524918 DOI: 10.1016/J.Jpsychires.2018.02.028 |
0.758 |
|
| 2018 |
Barnett I, Torous J, Staples P, Sandoval L, Keshavan M, Onnela J. Relapse prediction in schizophrenia through digital phenotyping: a pilot study. Neuropsychopharmacology. 43: 1660-1666. PMID 29511333 DOI: 10.1038/S41386-018-0030-Z |
0.364 |
|
| 2018 |
Cai H, Zhou X, Dougherty GG, Reddy RD, Haas GL, Montrose DM, Keshavan M, Yao JK. Pregnenolone-progesterone-allopregnanolone pathway as a potential therapeutic target in first-episode antipsychotic-naïve patients with schizophrenia. Psychoneuroendocrinology. 90: 43-51. PMID 29433072 DOI: 10.1016/J.Psyneuen.2018.02.004 |
0.381 |
|
| 2018 |
Torous J, Keshavan M. A new window into psychosis: The rise digital phenotyping, smartphone assessment, and mobile monitoring. Schizophrenia Research. 197: 67-68. PMID 29338959 DOI: 10.1016/J.Schres.2018.01.005 |
0.307 |
|
| 2018 |
Denis D, Sato E, Larson O, Kohnke EJ, Parr E, King J, Stewart K, Baran B, Keshavan M, Manoach D, Stickgold R. 0998 Sleep-dependent Memory Consolidation In Early Course Schizophrenia Patients And Familial High-risk Relatives Sleep. 41: A369-A370. DOI: 10.1093/Sleep/Zsy061.997 |
0.337 |
|
| 2018 |
Conus P, Fournier M, Xin L, Cleusix M, Baumann PS, Ferrari C, Cousins A, Alameda L, Gholam-Razaee M, Golay P, Jenni R, Woo TW, Keshavan M, Eap CB, Wojcik J, et al. F44. AN ADD-ON TRIAL WITH N-ACETYL-CYSTEINE (NAC) IN EARLY PSYCHOSIS PATIENTS: TOWARDS BIOMARKER GUIDED TREATMENT Schizophrenia Bulletin. 44: S236-S236. DOI: 10.1093/Schbul/Sby017.575 |
0.383 |
|
| 2018 |
Lyall A, Somes N, Zhang F, Robertson J, O’Donnell LJ, Rathi Y, Pasternak O, Savadjiev P, Styner M, Fitzgerald Z, Mesholam-Gately R, Thermenos H, Whitfield-Gabrieli S, Keshavan M, DeLisi L, et al. T201. THE STUDY OF WHITE MATTER MATURATION IN THREE POPULATIONS OF GENETIC HIGH RISK FOR SCHIZOPHRENIA INDIVIDUALS SPANNING THE DEVELOPMENTAL TIMELINE Schizophrenia Bulletin. 44: S194-S195. DOI: 10.1093/Schbul/Sby016.477 |
0.377 |
|
| 2018 |
Guimond S, Tingue S, Devenyi GA, Tang Y, Mike L, Mallar Chakravarty M, Sweeney JA, Pearlson GD, Clementz BA, Tamminga CA, Keshavan MS. T22. PITUITARY GLAND VOLUME DIFFERENCES IN INDIVIDUALS WITH PSYCHOSIS: RESULTS FROM THE BIPOLAR-SCHIZOPHRENIA NETWORK ON INTERMEDIATE PHENOTYPES (B-SNIP) STUDY Schizophrenia Bulletin. 44: S121-S121. DOI: 10.1093/Schbul/Sby016.298 |
0.353 |
|
| 2018 |
Reininghaus U, Boehnke J, Chavez-Baldini U, Clementz B, Pearlson G, Keshavan M, Sweeney J, Tamminga C. 5.3 EVIDENCE ON A TRANSDIAGNOSTIC PSYCHOSIS SPECTRUM OF SCHIZOPHRENIA, SCHIZOAFFECTIVE AND PSYCHOTIC BIPOLAR DISORDER IN THE BIPOLAR-SCHIZOPHRENIA NETWORK ON INTERMEDIATE PHENOTYPES (B-SNIP) Schizophrenia Bulletin. 44: S6-S7. DOI: 10.1093/Schbul/Sby014.015 |
0.466 |
|
| 2018 |
Brady R, Gonsalvez I, Schmahmann J, Keshavan M, Pascual-Leone A, Halko M. O7. Modulating Functional Connectivity to Ameliorate Negative Symptoms in Schizophrenia Biological Psychiatry. 83: S110-S111. DOI: 10.1016/J.Biopsych.2018.02.292 |
0.384 |
|
| 2018 |
Barnett I, Torous J, Staples P, Sandoval L, Keshavan M, Onnela J. 151. Relapse Prediction in Schizophrenia through Digital Phenotyping Biological Psychiatry. 83. DOI: 10.1016/J.Biopsych.2018.02.169 |
0.402 |
|
| 2018 |
Staples P, Torous J, Barnett I, Sandoval L, Keshavan M, Onnela JP. 149. Characterizing the Clinical Relevance of Digital Phenotyping Data Quality With Applications to a Cohort With Schizophrenia Biological Psychiatry. 83. DOI: 10.1016/J.Biopsych.2018.02.167 |
0.382 |
|
| 2018 |
Parker D, Trotti R, McDowell JE, Keedy S, Sweeney J, Gershon E, Pearlson G, Keshavan M, Tamminga C, Clementz B. 148. Auditory and Visual EEG Validators of Psychosis Biotypes, Findings From Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) Consortium Biological Psychiatry. 83: S60-S61. DOI: 10.1016/J.Biopsych.2018.02.166 |
0.397 |
|
| 2018 |
Kelly S, Guimond S, Sweeney J, Pearlson G, Clementz B, Tamminga C, Shenton M, Pasternak O, Keshavan M. 146. Diagnosis and Biotype Comparisons Across the Psychosis Spectrum: Investigating White Matter Microstructural Differences From the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) Study Using Free-Water Imaging Biological Psychiatry. 83: S59-S60. DOI: 10.1016/J.Biopsych.2018.02.164 |
0.413 |
|
| 2018 |
Guimond S, Kelly S, Mike L, Chakravarty MM, Sweeney J, Pearlson G, Clementz BA, Tamminga C, Keshavan M. 145. Diagnosis and Biotype Comparisons Across the Psychosis Spectrum: Investigating Amygdala-Hippocampal Differences From the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) Study Biological Psychiatry. 83: S59. DOI: 10.1016/J.Biopsych.2018.02.163 |
0.421 |
|
| 2018 |
Zhou X, Reddy R, Montrose D, Haas G, Keshavan M, Yao J. S218. A Potential Therapeutic Target of Plasma Free Fatty Acids in First-Episode Antipsychotic-Naïve Patients With Schizophrenia Biological Psychiatry. 83. DOI: 10.1016/J.Biopsych.2018.02.1110 |
0.361 |
|
| 2018 |
Trotti R, Parker D, Sabatinelli D, Tamminga C, Gershon E, Keedy S, Sweeney J, Keshavan M, Pearlson G, McDowell JE, Clementz BA. S188. Emotional processing in Bipolar Disorder With and Without Psychosis: Findings From the Psychosis and Affective Research Domains and Intermediate Phenotypes Consortium Biological Psychiatry. 83: S420. DOI: 10.1016/J.Biopsych.2018.02.1080 |
0.339 |
|
| 2018 |
Lewandowski K, Cohen B, Keshavan M, Ongur D. S115. Cortical Reserve Predicts Response to Cognitive Remediation in Bipolar Disorder Biological Psychiatry. 83: S391-S392. DOI: 10.1016/J.Biopsych.2018.02.1006 |
0.362 |
|
| 2017 |
Tamminga CA, Pearlson GD, Stan AD, Gibbons RD, Padmanabhan J, Keshavan M, Clementz BA. Strategies for Advancing Disease Definition Using Biomarkers and Genetics: The Bipolar and Schizophrenia Network for Intermediate Phenotypes. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. 2: 20-27. PMID 29560884 DOI: 10.1016/J.Bpsc.2016.07.005 |
0.363 |
|
| 2017 |
Lewandowski KE, Sperry SH, Cohen BM, Norris LA, Fitzmaurice GM, Ongur D, Keshavan MS. Treatment to Enhance Cognition in Bipolar Disorder (TREC-BD): Efficacy of a Randomized Controlled Trial of Cognitive Remediation Versus Active Control. The Journal of Clinical Psychiatry. PMID 29045770 DOI: 10.4088/Jcp.17M11476 |
0.333 |
|
| 2017 |
Blokland GAM, Del Re EC, Mesholam-Gately RI, Jovicich J, Trampush JW, Keshavan MS, DeLisi LE, Walters JTR, Turner JA, Malhotra AK, Lencz T, Shenton ME, Voineskos AN, Rujescu D, Giegling I, et al. The Genetics of Endophenotypes of Neurofunction to Understand Schizophrenia (GENUS) consortium: A collaborative cognitive and neuroimaging genetics project. Schizophrenia Research. PMID 28982554 DOI: 10.1016/J.Schres.2017.09.024 |
0.307 |
|
| 2017 |
Torous J, Staples P, Slaters L, Adams J, Sandoval L, Onnela JP, Keshavan M. Characterizing Smartphone Engagement for Schizophrenia: Results of a Naturalist Mobile Health Study. Clinical Schizophrenia & Related Psychoses. PMID 28777029 DOI: 10.3371/Csrp.Jtps.071317 |
0.382 |
|
| 2017 |
Hill K, Bolo N, Sarvode Mothi S, Lizano P, Guimond S, Tandon N, Molokotos E, Keshavan M. Subcortical surface shape in youth at familial high risk for schizophrenia. Psychiatry Research. 267: 36-44. PMID 28734178 DOI: 10.1016/J.Pscychresns.2017.07.002 |
0.487 |
|
| 2017 |
Hudgens-Haney ME, Ethridge LE, Knight JB, McDowell JE, Keedy SK, Pearlson GD, Tamminga CA, Keshavan MS, Sweeney JA, Clementz BA. Intrinsic neural activity differences among psychotic illnesses. Psychophysiology. PMID 28419491 DOI: 10.1111/Psyp.12875 |
0.304 |
|
| 2017 |
Brady RO, Margolis A, Masters GA, Keshavan M, Öngür D. Bipolar mood state reflected in cortico-amygdala resting state connectivity: A cohort and longitudinal study. Journal of Affective Disorders. 217: 205-209. PMID 28415008 DOI: 10.1016/J.Jad.2017.03.043 |
0.317 |
|
| 2017 |
Eum S, Hill SK, Rubin LH, Carnahan RM, Reilly JL, Ivleva EI, Keedy SK, Tamminga CA, Pearlson GD, Clementz BA, Gershon ES, Keshavan MS, Keefe RS, Sweeney JA, Bishop JR. Cognitive burden of anticholinergic medications in psychotic disorders. Schizophrenia Research. PMID 28390849 DOI: 10.1016/J.Schres.2017.03.034 |
0.323 |
|
| 2017 |
Du Y, Pearlson GD, Lin D, Sui J, Chen J, Salman M, Tamminga CA, Ivleva EI, Sweeney JA, Keshavan MS, Clementz BA, Bustillo J, Calhoun VD. Identifying dynamic functional connectivity biomarkers using GIG-ICA: Application to schizophrenia, schizoaffective disorder, and psychotic bipolar disorder. Human Brain Mapping. PMID 28294459 DOI: 10.1002/Hbm.23553 |
0.357 |
|
| 2017 |
Eack SM, Wojtalik JA, Keshavan MS, Minshew NJ. Social-cognitive brain function and connectivity during visual perspective-taking in autism and schizophrenia. Schizophrenia Research. PMID 28291690 DOI: 10.1016/J.Schres.2017.03.009 |
0.355 |
|
| 2017 |
Wojtalik JA, Smith MJ, Keshavan MS, Eack SM. A Systematic and Meta-analytic Review of Neural Correlates of Functional Outcome in Schizophrenia. Schizophrenia Bulletin. PMID 28204755 DOI: 10.1093/Schbul/Sbx008 |
0.317 |
|
| 2017 |
Francis A, Mothi S, Mathew I, Tandon N, Clementz B, Pearlson G, Sweeney J, Tamminga C, Keshavan M. SU83. Is the Anterior Splenium an Intermediate Phenotype Across the Psychosis Dimension? Schizophrenia Bulletin. 43: S191-S191. DOI: 10.1093/Schbul/Sbx024.079 |
0.307 |
|
| 2017 |
Wojcik J, Lynda T, Lutz O, Mesholam-Gately R, Sweeney J, Pearlson G, Clementz B, Tamminga CA, Keshavan MS. SU49. Do Psychosis Biotypes Differ Across Traditional Schizophrenia Subtypes? Schizophrenia Bulletin. 43: S178-S179. DOI: 10.1093/Schbul/Sbx024.047 |
0.377 |
|
| 2017 |
Karpouzian T, Sweeney J, Rubin L, McDowell J, Clementz B, Gershon E, Keshavan M, Pearlson G, Tamminga C, Reilly J. SU25. Lack of Pupillary Modulation by Antisaccade Performance in Schizophrenia, Schizoaffective Disorder, and Psychotic Bipolar Disorder Suggests Reduced Top-Down Control During Response Preparation on an Executive Control Task Schizophrenia Bulletin. 43: S169-S170. DOI: 10.1093/Schbul/Sbx024.023 |
0.417 |
|
| 2017 |
Yao J, Reddy R, Dougherty G, Magan S, Gurklis J, Sonel A, Sonel E, Kisslinger B, Chengappa KN, Keshavan M. SU6. Association of High Risk of Cardiovascular Disease With Increased Serum hsCRP Levels Progressively in Patients With Schizophrenia Schizophrenia Bulletin. 43: S162-S163. DOI: 10.1093/Schbul/Sbx024.005 |
0.326 |
|
| 2017 |
Schneider Z, Parker D, Kittle F, McDowell J, Buckley P, Keedy S, Gershon E, Sweeney J, Keshavan M, Pearlson G, Tamminga C, Clementz B. SU5. Investigation of the Visual Steady-State Response in Schizophrenia, Schizoaffective, Psychotic, and Nonpsychotic Bipolar Disorders Schizophrenia Bulletin. 43: S162-S162. DOI: 10.1093/Schbul/Sbx024.004 |
0.394 |
|
| 2017 |
Bishop J, Hill S, Mills L, Alliey-Rodriguez N, Reilly J, Shaffee R, McCarroll S, Keefe R, Pearlson G, Clementz B, Tamminga C, Keshavan M, Gershon E, Sweeney J. M94. Genetic Analyses of Cognitive Performance in Psychotic Disorders From the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) Consortium Schizophrenia Bulletin. 43: S245-S245. DOI: 10.1093/Schbul/Sbx022.089 |
0.442 |
|
| 2017 |
Torous J, Keshavan M, Onnela J, Staples P, Barnett I. M48. Digital Phenotyping in Schizophrenia Using Smartphones. Schizophrenia Bulletin. 43. DOI: 10.1093/Schbul/Sbx022.045 |
0.403 |
|
| 2017 |
Haut K, Saxena A, Yin H, Carol E, Dodell-Feder D, Lincoln SH, Tully L, Keshavan M, Seidman LJ, Nahum M, Hooker C. 219. Changes in Functional Networks Underlying Social Cognition Following Cognitive Training in Individuals at Risk for Psychosis Schizophrenia Bulletin. 43: S111-S111. DOI: 10.1093/Schbul/Sbx021.297 |
0.331 |
|
| 2017 |
Tandon N, Sudarshan M, Mothi S, Clementz BA, Pearlson GD, Sweeney J, Tamminga CA, Keshavan M. 205. Machine Learning to Further Improve Classification of Psychotic Disorders Using Clinical and Biological Stratification: Updates From the Bipolar Schizophrenia Network for Intermediate Phenotypes (BSNIP) Schizophrenia Bulletin. 43: S105-S105. DOI: 10.1093/Schbul/Sbx021.283 |
0.399 |
|
| 2017 |
Guimond S, Padani S, Lutz O, Eack S, Thermenos H, Keshavan M. 198. Impaired Emotion Regulation During Working Memory in Early Schizophrenia Schizophrenia Bulletin. 43: S103-S103. DOI: 10.1093/Schbul/Sbx021.276 |
0.363 |
|
| 2017 |
Prasad K, Nimgaonkar V, Keshavan M. 140. Inflammation Alters Brain Function in Critical Regions and Cognitive Performance in Schizophrenia Schizophrenia Bulletin. 43. DOI: 10.1093/Schbul/Sbx021.198 |
0.454 |
|
| 2017 |
Wojtalik J, Keshavan M, Eack S. 107. Ten-Year Durability Effects of Cognitive Enhancement Therapy in Early Course Schizophrenia Schizophrenia Bulletin. 43: S56-S56. DOI: 10.1093/Schbul/Sbx021.145 |
0.405 |
|
| 2017 |
Ivleva E, Clementz B, Dutcher A, Aslan S, Witte B, Poudyal G, Lu H, Meda S, Pearlson GD, Sweeney J, Keshavan M, Tamminga C. 10. Brain Structure Biomarkers at the Psychosis/Nonpsychosis Interphase: Findings From the Bipolar–Schizophrenia Network for Intermediate Phenotypes Schizophrenia Bulletin. 43: S10-S10. DOI: 10.1093/Schbul/Sbx021.029 |
0.459 |
|
| 2017 |
Tamminga C, Clementz B, Keshavan M, Gershon E, Pearlson G, Ivleva E. 5.3 Endophenotypes Guide Psychosis Neurobiology Formulations Schizophrenia Bulletin. 43: S7-S7. DOI: 10.1093/Schbul/Sbx021.019 |
0.359 |
|
| 2017 |
Tamminga C, Ivleva E, Clementz B, Sweeney J, Pearlson G, Keshavan M. 3.2 Can Neurobiological Subgroups in Psychotic Illness Advantage Drug DISCOVERY? Schizophrenia Bulletin. 43: S3-S3. DOI: 10.1093/Schbul/Sbx021.008 |
0.464 |
|
| 2017 |
Pearlson G, Meda S, Khadka S, Tamminga C, Keshavan M, Clementz B, Sweeney J, Gershon E, Raskin S, Fallahi C. APPLYING MULTIVARIATE TECHNIQUES, INCLUDING PARALLEL ICA TO COMMON COMPLEX PSYCHIATRIC ENDOPHENOTYPES European Neuropsychopharmacology. 27: S519. DOI: 10.1016/J.Euroneuro.2016.09.636 |
0.324 |
|
| 2017 |
Lencer R, Mills LJ, Alliey-Rodriguez N, Reilly JL, Sprenger A, McDowell JE, Keshavan MS, Pearlson GD, McCarroll S, Tamminga CA, Clementz BA, Gershon ES, Sweeney JA, Bishop JR. Genome-Wide Association Studies Of Smooth Pursuit Eye Movements Across Psychotic Disorders: Preliminary Findings From The B-Snip Sample European Neuropsychopharmacology. 27. DOI: 10.1016/J.Euroneuro.2016.09.580 |
0.339 |
|
| 2017 |
Hall M, Holton K, Chittenden T, Ongur D, Eklund K, Montrose D, Keshavan M. 486. Longitudinal Recovery Trajectories of Patients with First Episode Psychosis Biological Psychiatry. 81. DOI: 10.1016/J.Biopsych.2017.02.970 |
0.325 |
|
| 2017 |
Khadka S, Tamminga C, Keshavan M, Clementz B, Gershon E, Pearlson GD. 822. Abnormal Resting State Functional Connectivity in Bipolar Disorder with and without Psychosis Biological Psychiatry. 81: S333-S334. DOI: 10.1016/J.Biopsych.2017.02.889 |
0.381 |
|
| 2017 |
Lutz O, Lizano P, Mothi SS, Tandon N, Tamminga C, Clementz B, Sweeney J, Pearlson G, Keshavan M. 965. Investigating Brain Structure Across Bipolar Disorder Subtypes: Findings from the Psychosis Affective Research Domain Intermediate Phenotypes (PARDIP) Study Biological Psychiatry. 81. DOI: 10.1016/J.Biopsych.2017.02.691 |
0.366 |
|
| 2017 |
Torous J, Onnela JP, Staples P, Sandoval L, Barnett I, Keshavan M. 369. Digital Phenotyping in Schizophrenia Biological Psychiatry. 81. DOI: 10.1016/J.Biopsych.2017.02.386 |
0.42 |
|
| 2017 |
Torous J, Staples P, Sandoval L, Barnett I, Onnela JP, Keshavan M. 323. Utilizing Smartphones to Collect Longitudinal Digital Phenotypes in Patients with Schizophrenia Biological Psychiatry. 81. DOI: 10.1016/J.Biopsych.2017.02.338 |
0.429 |
|
| 2017 |
Brady R, Tandon N, Keshavan M, Ongur D. 271. Negative Symptoms of Schizophrenia and Fronto-Parietal Circuit Dysfunction Biological Psychiatry. 81: S111. DOI: 10.1016/J.Biopsych.2017.02.285 |
0.408 |
|
| 2017 |
Kelly S, Lutz O, Berman D, Yao L, Guimond S, Mike L, Thermenos H, Kubicki M, Eack S, Keshavan M. 270. White Matter Microstructure and Cognition in Early Schizophrenia Biological Psychiatry. 81: S111. DOI: 10.1016/J.Biopsych.2017.02.284 |
0.451 |
|
| 2017 |
Mike L, Guimond S, Chakravarty M, Thermenos H, Eack S, Keshavan M. 190. Social Cognition in Early Schizophrenia: Exploratory Factor Analysis and Subcortical Biomarkers Biological Psychiatry. 81: S79. DOI: 10.1016/J.Biopsych.2017.02.203 |
0.423 |
|
| 2017 |
Massa N, Bhattacharya A, Sweeney JA, Pearlson GD, Keshavan MS, Tamminga CA, Clementz BA, Duncan E. 62. Acoustic Startle Latency is Prolonged in Schizophrenia in the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) Cohort Biological Psychiatry. 81: S26. DOI: 10.1016/J.Biopsych.2017.02.073 |
0.315 |
|
| 2016 |
Meda SA, Clementz BA, Sweeney JA, Keshavan MS, Tamminga CA, Ivleva EI, Pearlson GD. Examining Functional Resting-State Connectivity in Psychosis and Its Subgroups in the Bipolar-Schizophrenia Network on Intermediate Phenotypes Cohort. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. 1: 488-497. PMID 29653095 DOI: 10.1016/J.Bpsc.2016.07.001 |
0.349 |
|
| 2016 |
Keshavan MS, Eack SM, Prasad KM, Haller CS, Cho RY. Longitudinal functional brain imaging study in early course schizophrenia before and after cognitive enhancement therapy. Neuroimage. PMID 27894892 DOI: 10.1016/J.Neuroimage.2016.11.060 |
0.338 |
|
| 2016 |
Lizano PL, Yao JK, Tandon N, Mothi SS, Montrose DM, Keshavan MS. Association of sFlt-1 and worsening psychopathology in relatives at high risk for psychosis: A longitudinal study. Schizophrenia Research. PMID 27863935 DOI: 10.1016/j.schres.2016.11.015 |
0.326 |
|
| 2016 |
Ivleva EI, Clementz BA, Dutcher AM, Arnold SJ, Jeon-Slaughter H, Aslan S, Witte B, Poudyal G, Lu H, Meda SA, Pearlson GD, Sweeney JA, Keshavan MS, Tamminga CA. Brain Structure Biomarkers in the Psychosis Biotypes: Findings From the Bipolar-Schizophrenia Network for Intermediate Phenotypes. Biological Psychiatry. PMID 27817844 DOI: 10.1016/J.Biopsych.2016.08.030 |
0.334 |
|
| 2016 |
Hager B, Yang AC, Brady R, Meda S, Clementz B, Pearlson GD, Sweeney JA, Tamminga C, Keshavan M. Neural complexity as a potential translational biomarker for psychosis. Journal of Affective Disorders. PMID 27814962 DOI: 10.1016/J.Jad.2016.10.016 |
0.377 |
|
| 2016 |
Tandon N, Nanda P, Padmanabhan JL, Mathew IT, Eack SM, Narayanan B, Meda SA, Bergen SE, Ruaño G, Windemuth A, Kocherla M, Petryshen TL, Clementz B, Sweeney J, Tamminga C, ... ... Keshavan MS, et al. Novel gene-brain structure relationships in psychotic disorder revealed using parallel independent component analyses. Schizophrenia Research. PMID 27789186 DOI: 10.1016/J.Schres.2016.10.026 |
0.362 |
|
| 2016 |
Brady RO, Tandon N, Masters GA, Margolis A, Cohen BM, Keshavan M, Öngür D. Differential brain network activity across mood states in bipolar disorder. Journal of Affective Disorders. 207: 367-376. PMID 27744225 DOI: 10.1016/J.Jad.2016.09.041 |
0.359 |
|
| 2016 |
Eack SM, Newhill CE, Keshavan MS. Cognitive Enhancement Therapy Improves Resting-State Functional Connectivity in Early Course Schizophrenia. Journal of the Society For Social Work and Research. 7: 211-230. PMID 27713804 DOI: 10.1086/686538 |
0.352 |
|
| 2016 |
Li X, Thermenos HW, Wu Z, Momura Y, Wu K, Keshavan M, Seidman L, DeLisi LE. Abnormal interactions of verbal- and spatial-memory networks in young people at familial high-risk for schizophrenia. Schizophrenia Research. PMID 27481817 DOI: 10.1016/J.Schres.2016.07.022 |
0.339 |
|
| 2016 |
Reilly JL, Hill SK, Gold JM, Keefe RS, Clementz BA, Gershon E, Keshavan MS, Pearlson G, Tamminga CA, Sweeney JA. Impaired Context Processing is Attributable to Global Neuropsychological Impairment in Schizophrenia and Psychotic Bipolar Disorder. Schizophrenia Bulletin. PMID 27306316 DOI: 10.1093/Schbul/Sbw081 |
0.375 |
|
| 2016 |
Mehta UM, Keshavan MS, Gangadhar BN. Bridging the schism of schizophrenia through yoga-Review of putative mechanisms. International Review of Psychiatry (Abingdon, England). 1-14. PMID 27187680 DOI: 10.1080/09540261.2016.1176905 |
0.335 |
|
| 2016 |
Brady RO, Masters GA, Mathew IT, Margolis A, Cohen BM, Öngür D, Keshavan M. State dependent cortico-amygdala circuit dysfunction in bipolar disorder. Journal of Affective Disorders. 201: 79-87. PMID 27177299 DOI: 10.1016/J.Jad.2016.04.052 |
0.375 |
|
| 2016 |
Hanna RC, Shalvoy A, Cullum CM, Ivleva EI, Keshavan M, Pearlson G, Hill SK, Sweeney JA, Tamminga CA, Ghose S. Cognitive Function in Individuals With Psychosis: Moderation by Adolescent Cannabis Use. Schizophrenia Bulletin. PMID 27033329 DOI: 10.1093/Schbul/Sbw030 |
0.469 |
|
| 2016 |
Lewandowski KE, Sperry SH, Ongur D, Cohen BM, Norris LA, Keshavan MS. Cognitive remediation versus active computer control in bipolar disorder with psychosis: study protocol for a randomized controlled trial. Trials. 17: 136. PMID 26969299 DOI: 10.1186/S13063-016-1275-7 |
0.366 |
|
| 2016 |
Torous J, Keshavan M. The role of social media in schizophrenia: evaluating risks, benefits, and potential Current Opinion in Psychiatry. 29: 190-195. PMID 26967314 DOI: 10.1097/Yco.0000000000000246 |
0.343 |
|
| 2016 |
Francis AN, Mothi SS, Mathew IT, Tandon N, Clementz B, Pearlson GD, Sweeney JA, Tamminga CA, Keshavan MS. Callosal Abnormalities Across the Psychosis Dimension: Bipolar Schizophrenia Network on Intermediate Phenotypes. Biological Psychiatry. PMID 26954565 DOI: 10.1016/J.Biopsych.2015.12.026 |
0.408 |
|
| 2015 |
Wang Z, Meda SA, Keshavan MS, Tamminga CA, Sweeney JA, Clementz BA, Schretlen DJ, Calhoun VD, Lui S, Pearlson GD. Large-Scale Fusion of Gray Matter and Resting-State Functional MRI Reveals Common and Distinct Biological Markers across the Psychosis Spectrum in the B-SNIP Cohort. Frontiers in Psychiatry. 6: 174. PMID 26732139 DOI: 10.3389/Fpsyt.2015.00174 |
0.375 |
|
| 2015 |
Nanda P, Tandon N, Mathew IT, Padmanabhan JL, Clementz BA, Pearlson GD, Sweeney JA, Tamminga CA, Keshavan MS. Impulsivity across the psychosis spectrum: Correlates of cortical volume, suicidal history, and social and global function. Schizophrenia Research. PMID 26711526 DOI: 10.1016/J.Schres.2015.11.030 |
0.322 |
|
| 2015 |
Hochberger WC, Hill SK, Nelson CL, Reilly JL, Keefe RS, Pearlson GD, Keshavan MS, Tamminga CA, Clementz BA, Sweeney JA. Unitary construct of generalized cognitive ability underlying BACS performance across psychotic disorders and in their first-degree relatives. Schizophrenia Research. PMID 26645510 DOI: 10.1016/J.Schres.2015.11.022 |
0.379 |
|
| 2015 |
Soh P, Narayanan B, Khadka S, Calhoun VD, Keshavan MS, Tamminga CA, Sweeney JA, Clementz BA, Pearlson GD. Joint Coupling of Awake EEG Frequency Activity and MRI Gray Matter Volumes in the Psychosis Dimension: A BSNIP Study. Frontiers in Psychiatry. 6: 162. PMID 26617533 DOI: 10.3389/Fpsyt.2015.00162 |
0.325 |
|
| 2015 |
Brady RO, Keshavan M. Emergent treatments based on the pathophysiology of bipolar disorder: A selective review. Asian Journal of Psychiatry. PMID 26525885 DOI: 10.1016/J.Ajp.2015.07.017 |
0.339 |
|
| 2015 |
Lencer R, Sprenger A, Reilly JL, McDowell JE, Rubin LH, Badner JA, Keshavan MS, Pearlson GD, Tamminga CA, Gershon ES, Clementz BA, Sweeney JA. Pursuit eye movements as an intermediate phenotype across psychotic disorders: Evidence from the B-SNIP study. Schizophrenia Research. PMID 26481615 DOI: 10.1016/J.Schres.2015.09.032 |
0.353 |
|
| 2015 |
Savadjiev P, Seidman LJ, Thermenos H, Keshavan M, Whitfield-Gabrieli S, Crow TJ, Kubicki M. Sexual dimorphic abnormalities in white matter geometry common to schizophrenia and non-psychotic high-risk subjects: Evidence for a neurodevelopmental risk marker? Human Brain Mapping. PMID 26467751 DOI: 10.1002/Hbm.23026 |
0.442 |
|
| 2015 |
Keshavan MS, Paus T. Neurodevelopmental Trajectories, Disconnection, and Schizophrenia Risk. Jama Psychiatry. 72: 943-5. PMID 26176634 DOI: 10.1001/jamapsychiatry.2015.1119 |
0.365 |
|
| 2015 |
Samudra N, Ivleva EI, Hubbard NA, Rypma B, Sweeney JA, Clementz BA, Keshavan MS, Pearlson GD, Tamminga CA. Alterations in hippocampal connectivity across the psychosis dimension. Psychiatry Research. 233: 148-57. PMID 26123450 DOI: 10.1016/J.Pscychresns.2015.06.004 |
0.34 |
|
| 2015 |
Narayanan B, Soh P, Calhoun VD, Ruaño G, Kocherla M, Windemuth A, Clementz BA, Tamminga CA, Sweeney JA, Keshavan MS, Pearlson GD. Multivariate genetic determinants of EEG oscillations in schizophrenia and psychotic bipolar disorder from the BSNIP study. Translational Psychiatry. 5: e588. PMID 26101851 DOI: 10.1038/Tp.2015.76 |
0.308 |
|
| 2015 |
Kristian Hill S, Buchholz A, Amsbaugh H, Reilly JL, Rubin LH, Gold JM, Keefe RS, Pearlson GD, Keshavan MS, Tamminga CA, Sweeney JA. Working memory impairment in probands with schizoaffective disorder and first degree relatives of schizophrenia probands extend beyond deficits predicted by generalized neuropsychological impairment. Schizophrenia Research. 166: 310-5. PMID 26008884 DOI: 10.1016/J.Schres.2015.05.018 |
0.304 |
|
| 2015 |
Keshavan MS, Mehta UM, Padmanabhan JL, Shah JL. Dysplasticity, metaplasticity, and schizophrenia: Implications for risk, illness, and novel interventions. Development and Psychopathology. 27: 615-35. PMID 25997775 DOI: 10.1017/S095457941500019X |
0.351 |
|
| 2015 |
Shad MU, Keshavan MS. Neurobiology of insight deficits in schizophrenia: An fMRI study. Schizophrenia Research. 165: 220-6. PMID 25957484 DOI: 10.1016/j.schres.2015.04.021 |
0.334 |
|
| 2015 |
Mothi SS, Tandon N, Padmanabhan J, Mathew IT, Clementz B, Tamminga C, Pearlson G, Sweeney J, Keshavan MS. Increased cardiometabolic dysfunction in first-degree relatives of patients with psychotic disorders. Schizophrenia Research. 165: 103-7. PMID 25900543 DOI: 10.1016/J.Schres.2015.03.034 |
0.311 |
|
| 2015 |
Jarskog LF, Lowy MT, Grove RA, Keefe RS, Horrigan JP, Ball MP, Breier A, Buchanan RW, Carter CS, Csernansky JG, Goff DC, Green MF, Kantrowitz JT, Keshavan MS, Laurelle M, et al. A Phase II study of a histamine H₃ receptor antagonist GSK239512 for cognitive impairment in stable schizophrenia subjects on antipsychotic therapy. Schizophrenia Research. 164: 136-42. PMID 25728831 DOI: 10.1016/J.Schres.2015.01.041 |
0.315 |
|
| 2015 |
Eack SM, Hogarty SS, Greenwald DP, Litschge MY, McKnight SA, Bangalore SS, Pogue-Geile MF, Keshavan MS, Cornelius JR. Cognitive Enhancement Therapy in substance misusing schizophrenia: results of an 18-month feasibility trial. Schizophrenia Research. 161: 478-83. PMID 25510926 DOI: 10.1016/J.Schres.2014.11.017 |
0.321 |
|
| 2015 |
Prasad KM, Upton CH, Schirda CS, Nimgaonkar VL, Keshavan MS. White matter diffusivity and microarchitecture among schizophrenia subjects and first-degree relatives. Schizophrenia Research. 161: 70-5. PMID 25454798 DOI: 10.1016/J.Schres.2014.09.045 |
0.342 |
|
| 2015 |
Prasad KM, Upton CH, Nimgaonkar VL, Keshavan MS. Differential susceptibility of white matter tracts to inflammatory mediators in schizophrenia: an integrated DTI study. Schizophrenia Research. 161: 119-25. PMID 25449712 DOI: 10.1016/J.Schres.2014.09.043 |
0.332 |
|
| 2015 |
Hill SK, Reilly JL, Ragozzino ME, Rubin LH, Bishop JR, Gur RC, Gershon ES, Tamminga CA, Pearlson GD, Keshavan MS, Keefe RS, Sweeney JA. Regressing to Prior Response Preference After Set Switching Implicates Striatal Dysfunction Across Psychotic Disorders: Findings From the B-SNIP Study. Schizophrenia Bulletin. 41: 940-50. PMID 25194139 DOI: 10.1093/Schbul/Sbu130 |
0.331 |
|
| 2015 |
Bishop JR, Reilly JL, Harris MS, Patel SR, Kittles R, Badner JA, Prasad KM, Nimgaonkar VL, Keshavan MS, Sweeney JA. Pharmacogenetic associations of the type-3 metabotropic glutamate receptor (GRM3) gene with working memory and clinical symptom response to antipsychotics in first-episode schizophrenia. Psychopharmacology. 232: 145-54. PMID 25096017 DOI: 10.1007/S00213-014-3649-4 |
0.301 |
|
| 2015 |
Lui S, Yao L, Xiao Y, Keedy SK, Reilly JL, Keefe RS, Tamminga CA, Keshavan MS, Pearlson GD, Gong Q, Sweeney JA. Resting-state brain function in schizophrenia and psychotic bipolar probands and their first-degree relatives. Psychological Medicine. 45: 97-108. PMID 25066779 DOI: 10.1017/S003329171400110X |
0.379 |
|
| 2015 |
Padmanabhan JL, Tandon N, Haller CS, Mathew IT, Eack SM, Clementz BA, Pearlson GD, Sweeney JA, Tamminga CA, Keshavan MS. Correlations between brain structure and symptom dimensions of psychosis in schizophrenia, schizoaffective, and psychotic bipolar I disorders. Schizophrenia Bulletin. 41: 154-62. PMID 24907239 DOI: 10.1093/Schbul/Sbu075 |
0.315 |
|
| 2015 |
Arnold SJ, Ivleva EI, Gopal TA, Reddy AP, Jeon-Slaughter H, Sacco CB, Francis AN, Tandon N, Bidesi AS, Witte B, Poudyal G, Pearlson GD, Sweeney JA, Clementz BA, Keshavan MS, et al. Hippocampal volume is reduced in schizophrenia and schizoaffective disorder but not in psychotic bipolar I disorder demonstrated by both manual tracing and automated parcellation (FreeSurfer). Schizophrenia Bulletin. 41: 233-49. PMID 24557771 DOI: 10.1093/Schbul/Sbu009 |
0.338 |
|
| 2015 |
Hochberger W, Hill S, Nelson C, Pearlson G, Keshavan M, Tamminga C, Sweeney J, Reilly J. A-38Exploratory and Confirmatory Factor Analysis Converge on a Unitary Construct Underlying BACS Performance Across Psychotic Disorders, Their First-Degree Relatives, and Healthy Volunteers Archives of Clinical Neuropsychology. 30: 499.2-500. DOI: 10.1093/Arclin/Acv047.38 |
0.338 |
|
| 2014 |
Mehta UM, Thirthalli J, Aneelraj D, Jadhav P, Gangadhar BN, Keshavan MS. Mirror neuron dysfunction in schizophrenia and its functional implications: a systematic review. Schizophrenia Research. 160: 9-19. PMID 25468183 DOI: 10.1016/j.schres.2014.10.040 |
0.35 |
|
| 2014 |
Manoach DS, Demanuele C, Wamsley EJ, Vangel M, Montrose DM, Miewald J, Kupfer D, Buysse D, Stickgold R, Keshavan MS. Sleep spindle deficits in antipsychotic-naïve early course schizophrenia and in non-psychotic first-degree relatives. Frontiers in Human Neuroscience. 8: 762. PMID 25339881 DOI: 10.3389/Fnhum.2014.00762 |
0.339 |
|
| 2014 |
McGorry P, Keshavan M, Goldstone S, Amminger P, Allott K, Berk M, Lavoie S, Pantelis C, Yung A, Wood S, Hickie I. Biomarkers and clinical staging in psychiatry. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 13: 211-23. PMID 25273285 DOI: 10.1002/Wps.20144 |
0.31 |
|
| 2014 |
Ethridge LE, Soilleux M, Nakonezny PA, Reilly JL, Hill SK, Keefe RS, Gershon ES, Pearlson GD, Tamminga CA, Keshavan MS, Sweeney JA. Behavioral response inhibition in psychotic disorders: diagnostic specificity, familiality and relation to generalized cognitive deficit. Schizophrenia Research. 159: 491-8. PMID 25261042 DOI: 10.1016/J.Schres.2014.08.025 |
0.377 |
|
| 2014 |
Haller CS, Padmanabhan JL, Lizano P, Torous J, Keshavan M. Recent advances in understanding schizophrenia. F1000prime Reports. 6: 57. PMID 25184047 DOI: 10.12703/P6-57 |
0.473 |
|
| 2014 |
Ruocco AC, Reilly JL, Rubin LH, Daros AR, Gershon ES, Tamminga CA, Pearlson GD, Hill SK, Keshavan MS, Gur RC, Sweeney JA. Emotion recognition deficits in schizophrenia-spectrum disorders and psychotic bipolar disorder: Findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. Schizophrenia Research. 158: 105-12. PMID 25052782 DOI: 10.1016/J.Schres.2014.07.001 |
0.37 |
|
| 2014 |
Brent BK, Seidman LJ, Coombs G, Keshavan MS, Moran JM, Holt DJ. Neural responses during social reflection in relatives of schizophrenia patients: relationship to subclinical delusions. Schizophrenia Research. 157: 292-8. PMID 24951401 DOI: 10.1016/J.Schres.2014.05.033 |
0.325 |
|
| 2014 |
Mehta UM, Thirthalli J, Bhagyavathi HD, Keshav Kumar J, Subbakrishna DK, Gangadhar BN, Eack SM, Keshavan MS. Similar and contrasting dimensions of social cognition in schizophrenia and healthy subjects. Schizophrenia Research. 157: 70-7. PMID 24910445 DOI: 10.1016/J.Schres.2014.05.018 |
0.332 |
|
| 2014 |
Keshavan M. Talk therapy results speak for themselves Science. 344: 1099-1099. PMID 24904148 DOI: 10.1126/Science.344.6188.1099-A |
0.392 |
|
| 2014 |
Mathew I, Gardin TM, Tandon N, Eack S, Francis AN, Seidman LJ, Clementz B, Pearlson GD, Sweeney JA, Tamminga CA, Keshavan MS. Medial temporal lobe structures and hippocampal subfields in psychotic disorders: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. Jama Psychiatry. 71: 769-77. PMID 24828364 DOI: 10.1001/Jamapsychiatry.2014.453 |
0.399 |
|
| 2014 |
Meda SA, Ruaño G, Windemuth A, O'Neil K, Berwise C, Dunn SM, Boccaccio LE, Narayanan B, Kocherla M, Sprooten E, Keshavan MS, Tamminga CA, Sweeney JA, Clementz BA, Calhoun VD, et al. Multivariate analysis reveals genetic associations of the resting default mode network in psychotic bipolar disorder and schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 111: E2066-75. PMID 24778245 DOI: 10.1073/Pnas.1313093111 |
0.334 |
|
| 2014 |
Rubin LH, Carter CS, Bishop JR, Pournajafi-Nazarloo H, Drogos LL, Hill SK, Ruocco AC, Keedy SK, Reilly JL, Keshavan MS, Pearlson GD, Tamminga CA, Gershon ES, Sweeney JA. Reduced levels of vasopressin and reduced behavioral modulation of oxytocin in psychotic disorders. Schizophrenia Bulletin. 40: 1374-84. PMID 24619535 DOI: 10.1093/Schbul/Sbu027 |
0.367 |
|
| 2014 |
Tamminga CA, Pearlson G, Keshavan M, Sweeney J, Clementz B, Thaker G. Bipolar and schizophrenia network for intermediate phenotypes: outcomes across the psychosis continuum. Schizophrenia Bulletin. 40: S131-7. PMID 24562492 DOI: 10.1093/Schbul/Sbt179 |
0.469 |
|
| 2014 |
Narayanan B, O'Neil K, Berwise C, Stevens MC, Calhoun VD, Clementz BA, Tamminga CA, Sweeney JA, Keshavan MS, Pearlson GD. Resting state electroencephalogram oscillatory abnormalities in schizophrenia and psychotic bipolar patients and their relatives from the bipolar and schizophrenia network on intermediate phenotypes study. Biological Psychiatry. 76: 456-65. PMID 24439302 DOI: 10.1016/J.Biopsych.2013.12.008 |
0.37 |
|
| 2014 |
Nanda P, Tandon N, Mathew IT, Giakoumatos CI, Abhishekh HA, Clementz BA, Pearlson GD, Sweeney J, Tamminga CA, Keshavan MS. Local gyrification index in probands with psychotic disorders and their first-degree relatives. Biological Psychiatry. 76: 447-55. PMID 24369266 DOI: 10.1016/J.Biopsych.2013.11.018 |
0.324 |
|
| 2014 |
Brady R, Öngür D, Keshavan M. Neurobiology of mood-state shifts in bipolar disorder: a selective review and a hypothesis. Harvard Review of Psychiatry. 22: 23-30. PMID 24335514 DOI: 10.1097/Hrp.0000000000000004 |
0.331 |
|
| 2014 |
Unschuld PG, Buchholz AS, Varvaris M, van Zijl PC, Ross CA, Pekar JJ, Hock C, Sweeney JA, Tamminga CA, Keshavan MS, Pearlson GD, Thaker GK, Schretlen DJ. Prefrontal brain network connectivity indicates degree of both schizophrenia risk and cognitive dysfunction. Schizophrenia Bulletin. 40: 653-64. PMID 23778975 DOI: 10.1093/schbul/sbt077 |
0.343 |
|
| 2014 |
Brent BK, Coombs G, Keshavan MS, Seidman LJ, Moran JM, Holt DJ. Subclinical delusional thinking predicts lateral temporal cortex responses during social reflection. Social Cognitive and Affective Neuroscience. 9: 273-82. PMID 23160817 DOI: 10.7490/F1000Research.1090655.1 |
0.365 |
|
| 2014 |
Manoach D, Demanuele C, Wamsley E, Montrose D, Miewald J, Kupfer D, Buysse D, Stickgold R, Keshavan M. Sleep spindle deficits in young non-psychotic relatives of patients with schizophrenia F1000research. 5. DOI: 10.7490/F1000Research.1095515.1 |
0.377 |
|
| 2014 |
Padmanabhan J, Tandon N, Haller C, Mathew I, Ruano G, Windemuth A, Clementz B, Sweeney J, Pearlson GD, Tamminga C, Keshavan M. Poster #S141 ASSOCIATIONS BETWEEN POLYGENIC RISK SCORES FOR TYPE 2 DIABETES MELLITUS AND CO-MORBID DIABETES IN A SAMPLE OF SUBJECTS WITH SCHIZOPHRENIA, SCHIZOAFFECTIVE, OR BIPOLAR I DISORDERS Schizophrenia Research. 153. DOI: 10.1016/S0920-9964(14)70420-7 |
0.343 |
|
| 2014 |
Keshavan M. Sleep Eeg Studies In Schizophrenia: Methodological Considerations Schizophrenia Research. 153. DOI: 10.1016/S0920-9964(14)70278-6 |
0.345 |
|
| 2014 |
Pearlson GD, Tamminga C, Keshavan M, Thaker G, Clementz B, Sweeney J, Meda S, Khadka S. STRUCTURAL AND FUNCTIONAL NEUROIMAGING FINDINGS IN THE BSNIP PSYCHOSIS CONSORTIUM Schizophrenia Research. 153: S13-S14. DOI: 10.1016/S0920-9964(14)70041-6 |
0.302 |
|
| 2013 |
Ivleva EI, Bidesi AS, Keshavan MS, Pearlson GD, Meda SA, Dodig D, Moates AF, Lu H, Francis AN, Tandon N, Schretlen DJ, Sweeney JA, Clementz BA, Tamminga CA. Gray matter volume as an intermediate phenotype for psychosis: Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP). The American Journal of Psychiatry. 170: 1285-96. PMID 24185241 DOI: 10.1176/Appi.Ajp.2013.13010126 |
0.399 |
|
| 2013 |
Thermenos HW, Keshavan MS, Juelich RJ, Molokotos E, Whitfield-Gabrieli S, Brent BK, Makris N, Seidman LJ. A review of neuroimaging studies of young relatives of individuals with schizophrenia: a developmental perspective from schizotaxia to schizophrenia. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 162: 604-35. PMID 24132894 DOI: 10.1002/Ajmg.B.32170 |
0.375 |
|
| 2013 |
Eack SM, Wojtalik JA, Newhill CE, Keshavan MS, Phillips ML. Prefrontal cortical dysfunction during visual perspective-taking in schizophrenia. Schizophrenia Research. 150: 491-7. PMID 24055199 DOI: 10.1016/J.Schres.2013.08.022 |
0.381 |
|
| 2013 |
Brent BK, Thermenos HW, Keshavan MS, Seidman LJ. Gray matter alterations in schizophrenia high-risk youth and early-onset schizophrenia: a review of structural MRI findings. Child and Adolescent Psychiatric Clinics of North America. 22: 689-714. PMID 24012081 DOI: 10.1016/J.Chc.2013.06.003 |
0.338 |
|
| 2013 |
Hamm JP, Ethridge LE, Shapiro JR, Pearlson GD, Tamminga CA, Sweeney JA, Keshavan MS, Thaker GK, Clementz BA. Family history of psychosis moderates early auditory cortical response abnormalities in non-psychotic bipolar disorder. Bipolar Disorders. 15: 774-86. PMID 23941660 DOI: 10.1111/Bdi.12110 |
0.312 |
|
| 2013 |
Keshavan MS, Tandon R, Nasrallah HA. Renaming schizophrenia: keeping up with the facts. Schizophrenia Research. 148: 1-2. PMID 23849885 DOI: 10.1016/j.schres.2013.06.037 |
0.312 |
|
| 2013 |
Tamminga CA, Ivleva EI, Keshavan MS, Pearlson GD, Clementz BA, Witte B, Morris DW, Bishop J, Thaker GK, Sweeney JA. Clinical phenotypes of psychosis in the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP). The American Journal of Psychiatry. 170: 1263-74. PMID 23846857 DOI: 10.1176/Appi.Ajp.2013.12101339 |
0.365 |
|
| 2013 |
Mehta UM, Thirthalli J, Naveen Kumar C, Keshav Kumar J, Keshavan MS, Gangadhar BN. Schizophrenia patients experience substantial social cognition deficits across multiple domains in remission. Asian Journal of Psychiatry. 6: 324-9. PMID 23810141 DOI: 10.1016/j.ajp.2013.02.001 |
0.367 |
|
| 2013 |
Lewandowski KE, Cohen BM, Keshavan MS, Sperry SH, Ongür D. Neuropsychological functioning predicts community outcomes in affective and non-affective psychoses: a 6-month follow-up. Schizophrenia Research. 148: 34-7. PMID 23791391 DOI: 10.1016/J.Schres.2013.05.012 |
0.349 |
|
| 2013 |
Tandon N, Bolo NR, Sanghavi K, Mathew IT, Francis AN, Stanley JA, Keshavan MS. Brain metabolite alterations in young adults at familial high risk for schizophrenia using proton magnetic resonance spectroscopy. Schizophrenia Research. 148: 59-66. PMID 23791389 DOI: 10.1016/J.Schres.2013.05.024 |
0.306 |
|
| 2013 |
Skudlarski P, Schretlen DJ, Thaker GK, Stevens MC, Keshavan MS, Sweeney JA, Tamminga CA, Clementz BA, O'Neil K, Pearlson GD. Diffusion tensor imaging white matter endophenotypes in patients with schizophrenia or psychotic bipolar disorder and their relatives. The American Journal of Psychiatry. 170: 886-98. PMID 23771210 DOI: 10.1176/Appi.Ajp.2013.12111448 |
0.4 |
|
| 2013 |
Hill SK, Reilly JL, Keefe RS, Gold JM, Bishop JR, Gershon ES, Tamminga CA, Pearlson GD, Keshavan MS, Sweeney JA. Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. The American Journal of Psychiatry. 170: 1275-84. PMID 23771174 DOI: 10.1176/Appi.Ajp.2013.12101298 |
0.399 |
|
| 2013 |
Eack SM, Bahorik AL, McKnight SA, Hogarty SS, Greenwald DP, Newhill CE, Phillips ML, Keshavan MS, Minshew NJ. Commonalities in social and non-social cognitive impairments in adults with autism spectrum disorder and schizophrenia. Schizophrenia Research. 148: 24-8. PMID 23768814 DOI: 10.1016/J.Schres.2013.05.013 |
0.352 |
|
| 2013 |
Khadka S, Meda SA, Stevens MC, Glahn DC, Calhoun VD, Sweeney JA, Tamminga CA, Keshavan MS, O'Neil K, Schretlen D, Pearlson GD. Is aberrant functional connectivity a psychosis endophenotype? A resting state functional magnetic resonance imaging study. Biological Psychiatry. 74: 458-66. PMID 23746539 DOI: 10.1016/J.Biopsych.2013.04.024 |
0.309 |
|
| 2013 |
Mehta UM, Thirthalli J, Subbakrishna DK, Gangadhar BN, Eack SM, Keshavan MS. Social and neuro-cognition as distinct cognitive factors in schizophrenia: a systematic review. Schizophrenia Research. 148: 3-11. PMID 23732017 DOI: 10.1016/J.Schres.2013.05.009 |
0.334 |
|
| 2013 |
Romo-Nava F, Hoogenboom WS, Pelavin PE, Alvarado JL, Bobrow LH, Macmaster FP, Keshavan M, McCarley RW, Shenton ME. Pituitary volume in schizophrenia spectrum disorders. Schizophrenia Research. 146: 301-7. PMID 23522905 DOI: 10.1016/J.Schres.2013.02.024 |
0.63 |
|
| 2013 |
Keshavan MS, Kaneko Y. Secondary psychoses: an update. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 12: 4-15. PMID 23471787 DOI: 10.1002/wps.20001 |
0.313 |
|
| 2013 |
Fusar-Poli P, Borgwardt S, Bechdolf A, Addington J, Riecher-Rössler A, Schultze-Lutter F, Keshavan M, Wood S, Ruhrmann S, Seidman LJ, Valmaggia L, Cannon T, Velthorst E, De Haan L, Cornblatt B, et al. The psychosis high-risk state: a comprehensive state-of-the-art review. Jama Psychiatry. 70: 107-20. PMID 23165428 DOI: 10.1001/Jamapsychiatry.2013.269 |
0.313 |
|
| 2013 |
Wojtalik JA, Eack SM, Keshavan MS. Structural neurobiological correlates of Mayer-Salovery-Caruso Emotional Intelligence Test performance in early course schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 40: 207-12. PMID 23041620 DOI: 10.1016/J.Pnpbp.2012.09.013 |
0.336 |
|
| 2013 |
Francis AN, Bhojraj TS, Prasad KM, Montrose D, Eack SM, Rajarethinam R, van Elst LT, Keshavan MS. Alterations in the cerebral white matter of genetic high risk offspring of patients with schizophrenia spectrum disorder. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 40: 187-92. PMID 22910323 DOI: 10.1016/J.Pnpbp.2012.08.003 |
0.353 |
|
| 2012 |
Kaneko Y, Keshavan M. Cognitive remediation in schizophrenia. Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology. 10: 125-35. PMID 23430145 DOI: 10.9758/cpn.2012.10.3.125 |
0.314 |
|
| 2012 |
Ivleva EI, Bidesi AS, Thomas BP, Meda SA, Francis A, Moates AF, Witte B, Keshavan MS, Tamminga CA. Brain gray matter phenotypes across the psychosis dimension. Psychiatry Research. 204: 13-24. PMID 23177922 DOI: 10.1016/J.Pscychresns.2012.05.001 |
0.366 |
|
| 2012 |
Wojtalik JA, Eack SM, Pollock BG, Keshavan MS. Prefrontal gray matter morphology mediates the association between serum anticholinergicity and cognitive functioning in early course schizophrenia. Psychiatry Research. 204: 61-7. PMID 23158779 DOI: 10.1016/J.Pscychresns.2012.04.014 |
0.404 |
|
| 2012 |
Yung AR, Woods SW, Ruhrmann S, Addington J, Schultze-Lutter F, Cornblatt BA, Amminger GP, Bechdolf A, Birchwood M, Borgwardt S, Cannon TD, de Haan L, French P, Fusar-Poli P, Keshavan M, et al. Whither the attenuated psychosis syndrome? Schizophrenia Bulletin. 38: 1130-4. PMID 23144056 DOI: 10.1093/Schbul/Sbs108 |
0.424 |
|
| 2012 |
Stolz E, Pancholi KM, Goradia DD, Paul S, Keshavan MS, Nimgaonkar VL, Prasad KM. Brain activation patterns during visual episodic memory processing among first-degree relatives of schizophrenia subjects. Neuroimage. 63: 1154-61. PMID 22992490 DOI: 10.1016/J.Neuroimage.2012.08.030 |
0.335 |
|
| 2012 |
Yao JK, Condray R, Dougherty GG, Keshavan MS, Montrose DM, Matson WR, McEvoy J, Kaddurah-Daouk R, Reddy RD. Associations between purine metabolites and clinical symptoms in schizophrenia. Plos One. 7: e42165. PMID 22916123 DOI: 10.1371/Journal.Pone.0042165 |
0.306 |
|
| 2012 |
Francis AN, Seidman LJ, Jabbar GA, Mesholam-Gately R, Thermenos HW, Juelich R, Proal AC, Shenton M, Kubicki M, Mathew I, Keshavan M, DeLisi LE. Alterations in brain structures underlying language function in young adults at high familial risk for schizophrenia Schizophrenia Research. 141: 65-71. PMID 22892286 DOI: 10.1016/J.Schres.2012.07.015 |
0.305 |
|
| 2012 |
Kaddurah-Daouk R, McEvoy J, Baillie R, Zhu H, K Yao J, Nimgaonkar VL, Buckley PF, Keshavan MS, Georgiades A, Nasrallah HA. Impaired plasmalogens in patients with schizophrenia. Psychiatry Research. 198: 347-52. PMID 22513041 DOI: 10.1016/J.Psychres.2012.02.019 |
0.336 |
|
| 2012 |
Meda SA, Gill A, Stevens MC, Lorenzoni RP, Glahn DC, Calhoun VD, Sweeney JA, Tamminga CA, Keshavan MS, Thaker G, Pearlson GD. Differences in resting-state functional magnetic resonance imaging functional network connectivity between schizophrenia and psychotic bipolar probands and their unaffected first-degree relatives. Biological Psychiatry. 71: 881-9. PMID 22401986 DOI: 10.1016/J.Biopsych.2012.01.025 |
0.345 |
|
| 2012 |
Diwadkar VA, Wadehra S, Pruitt P, Keshavan MS, Rajan U, Zajac-Benitez C, Eickhoff SB. Disordered corticolimbic interactions during affective processing in children and adolescents at risk for schizophrenia revealed by functional magnetic resonance imaging and dynamic causal modeling. Archives of General Psychiatry. 69: 231-42. PMID 22393216 DOI: 10.1001/Archgenpsychiatry.2011.1349 |
0.342 |
|
| 2012 |
Murthy NV, Mahncke H, Wexler BE, Maruff P, Inamdar A, Zucchetto M, Lund J, Shabbir S, Shergill S, Keshavan M, Kapur S, Laruelle M, Alexander R. Computerized cognitive remediation training for schizophrenia: an open label, multi-site, multinational methodology study. Schizophrenia Research. 139: 87-91. PMID 22342330 DOI: 10.1016/J.Schres.2012.01.042 |
0.357 |
|
| 2012 |
Tandon N, Montrose D, Shah J, Rajarethinam RP, Diwadkar VA, Keshavan MS. Early prodromal symptoms can predict future psychosis in familial high-risk youth. Journal of Psychiatric Research. 46: 105-10. PMID 22056319 DOI: 10.1016/j.jpsychires.2011.09.019 |
0.312 |
|
| 2012 |
Diwadkar VA, Pruitt P, Zhang A, Radwan J, Keshavan MS, Murphy E, Rajan U, Zajac-Benitez C. The neural correlates of performance in adolescents at risk for schizophrenia: inefficiently increased cortico-striatal responses measured with fMRI. Journal of Psychiatric Research. 46: 12-21. PMID 22033368 DOI: 10.1016/J.Jpsychires.2011.09.016 |
0.311 |
|
| 2012 |
Shashi V, Veerapandiyan A, Schoch K, Kwapil T, Keshavan M, Ip E, Hooper S. Social skills and associated psychopathology in children with chromosome 22q11.2 deletion syndrome: Implications for interventions Journal of Intellectual Disability Research. 56: 865-878. PMID 21883601 DOI: 10.1111/J.1365-2788.2011.01477.X |
0.329 |
|
| 2012 |
Francis AN, Jabbar GA, Thermenos HW, Seidman LJ, Juelich R, Proal A, Kubicki M, Shenton M, Keshavan M, DeLisi LE. Poster #49 NEUROANATOMICAL ALTERATIONS IN REGIONS MEDIATING LANGUAGE IN YOUNG ADULTS AT HIGH RISK FOR INHERITANCE OF SCHIZOPHRENIA (GHR) Schizophrenia Research. 136: S203. DOI: 10.1016/S0920-9964(12)70621-7 |
0.513 |
|
| 2012 |
Pelisi LE, Thermenos HW, Seidman LJ, Whitfielf-Gabrieli S, Juelich R, Jabbar GA, Salwen K, Shenton M, Kubicki M, Gabrieli JD, Manschreck T, Francis A, Keshavan M. Poster #108 ALTERED LANGUAGE NETWORK ACTIVITY IN YOUNG PEOPLE AT GENETIC RISK FOR SCHIZOPHRENIA Schizophrenia Research. 136: S130. DOI: 10.1016/S0920-9964(12)70423-1 |
0.348 |
|
| 2011 |
Shad MU, Brent BK, Keshavan MS. Neurobiology of self-awareness deficits in schizophrenia: A hypothetical model. Asian Journal of Psychiatry. 4: 248-54. PMID 23051156 DOI: 10.1016/j.ajp.2011.09.002 |
0.34 |
|
| 2011 |
Shad MU, Brent BK, Keshavan MS. Neurobiology of self-awareness deficits in schizophrenia: A hypothetical model. Asian Journal of Psychiatry. 4: 248-54. PMID 23051156 DOI: 10.1016/j.ajp.2011.09.002 |
0.34 |
|
| 2011 |
Nasrallah H, Tandon R, Keshavan M. Beyond the facts in schizophrenia: closing the gaps in diagnosis, pathophysiology, and treatment Epidemiology and Psychiatric Sciences. 20: 317-327. PMID 22201209 DOI: 10.1017/S204579601100062X |
0.445 |
|
| 2011 |
Keshavan MS, Morris DW, Sweeney JA, Pearlson G, Thaker G, Seidman LJ, Eack SM, Tamminga C. A dimensional approach to the psychosis spectrum between bipolar disorder and schizophrenia: the Schizo-Bipolar Scale. Schizophrenia Research. 133: 250-4. PMID 21996268 DOI: 10.1016/J.Schres.2011.09.005 |
0.357 |
|
| 2011 |
Lewandowski KE, Cohen BM, Keshavan MS, Ongür D. Relationship of neurocognitive deficits to diagnosis and symptoms across affective and non-affective psychoses. Schizophrenia Research. 133: 212-7. PMID 21996265 DOI: 10.1016/J.Schres.2011.09.004 |
0.335 |
|
| 2011 |
Rajarethinam R, Venkatesh BK, Peethala R, Phan KL, Keshavan M. Reduced activation of superior temporal gyrus during auditory comprehension in young offspring of patients with schizophrenia. Schizophrenia Research. 130: 101-5. PMID 21684722 DOI: 10.1016/J.Schres.2011.05.025 |
0.405 |
|
| 2011 |
Keshavan MS, Eack SM, Wojtalik JA, Prasad KM, Francis AN, Bhojraj TS, Greenwald DP, Hogarty SS. A broad cortical reserve accelerates response to cognitive enhancement therapy in early course schizophrenia. Schizophrenia Research. 130: 123-9. PMID 21645997 DOI: 10.1016/J.Schres.2011.05.001 |
0.337 |
|
| 2011 |
Prasad KM, Eack SM, Goradia D, Pancholi KM, Keshavan MS, Yolken RH, Nimgaonkar VL. Progressive gray matter loss and changes in cognitive functioning associated with exposure to herpes simplex virus 1 in schizophrenia: a longitudinal study. The American Journal of Psychiatry. 168: 822-30. PMID 21632649 DOI: 10.1176/Appi.Ajp.2011.10101423 |
0.31 |
|
| 2011 |
Diwadkar VA, Goradia D, Hosanagar A, Mermon D, Montrose DM, Birmaher B, Axelson D, Rajarathinem R, Haddad L, Amirsadri A, Zajac-Benitez C, Rajan U, Keshavan MS. Working memory and attention deficits in adolescent offspring of schizophrenia or bipolar patients: comparing vulnerability markers. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 35: 1349-54. PMID 21549798 DOI: 10.1016/j.pnpbp.2011.04.009 |
0.368 |
|
| 2011 |
Keshavan MS, Brady R. Biomarkers in schizophrenia: we need to rebuild the Titanic. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 10: 35-6. PMID 21379351 DOI: 10.1002/J.2051-5545.2011.TB00008.X |
0.302 |
|
| 2011 |
Keshavan MS, Nasrallah HA, Tandon R. Schizophrenia, "Just the Facts" 6. Moving ahead with the schizophrenia concept: from the elephant to the mouse. Schizophrenia Research. 127: 3-13. PMID 21316923 DOI: 10.1016/j.schres.2011.01.011 |
0.358 |
|
| 2011 |
Reddy R, Fleet-Michaliszyn S, Condray R, Yao JK, Keshavan MS, Reddy R. Reduction in perseverative errors with adjunctive ethyl-eicosapentaenoic acid in patients with schizophrenia: Preliminary study. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 84: 79-83. PMID 21211955 DOI: 10.1016/J.Plefa.2010.12.001 |
0.329 |
|
| 2011 |
Lewandowski KE, Eack SM, Hogarty SS, Greenwald DP, Keshavan MS. Is cognitive enhancement therapy equally effective for patients with schizophrenia and schizoaffective disorder? Schizophrenia Research. 125: 291-4. PMID 21167689 DOI: 10.1016/J.Schres.2010.11.017 |
0.315 |
|
| 2011 |
Francis AN, Bhojraj TS, Prasad KM, Kulkarni S, Montrose DM, Eack SM, Keshavan MS. Abnormalities of the corpus callosum in non-psychotic high-risk offspring of schizophrenia patients. Psychiatry Research. 191: 9-15. PMID 21145214 DOI: 10.1016/J.Pscychresns.2010.09.007 |
0.35 |
|
| 2011 |
Eack SM, Pogue-Geile MF, Greenwald DP, Hogarty SS, Keshavan MS. Mechanisms of functional improvement in a 2-year trial of cognitive enhancement therapy for early schizophrenia. Psychological Medicine. 41: 1253-61. PMID 20860867 DOI: 10.1017/S0033291710001765 |
0.319 |
|
| 2011 |
Venkatasubramanian G, Jayakumar PN, Keshavan MS, Gangadhar BN. Schneiderian first rank symptoms and inferior parietal lobule cortical thickness in antipsychotic-naïve schizophrenia Progress in Neuro-Psychopharmacology and Biological Psychiatry. 35: 40-46. PMID 20688126 DOI: 10.1016/j.pnpbp.2010.07.023 |
0.35 |
|
| 2011 |
Bhojraj TS, Sweeney JA, Prasad KM, Eack SM, Francis AN, Miewald JM, Montrose DM, Keshavan MS. Gray matter loss in young relatives at risk for schizophrenia: relation with prodromal psychopathology. Neuroimage. 54: S272-9. PMID 20441795 DOI: 10.1016/J.Neuroimage.2010.04.257 |
0.342 |
|
| 2011 |
Bhojraj TS, Francis AN, Montrose DM, Keshavan MS. Grey matter and cognitive deficits in young relatives of schizophrenia patients. Neuroimage. 54: S287-92. PMID 20362681 DOI: 10.1016/j.neuroimage.2010.03.069 |
0.328 |
|
| 2011 |
Chandrasekaran A, Mears R, Ramaswamy S, Tandon N, Mudan A, Mitra P, Hajj MA, Hamil A, Nordin M, Wojcik J, McInnis M, Boutros N, Pearlson G, Sweeney J, Tamminga C, ... ... Keshavan M, et al. Preliminary studies of altered synchronous gamma oscillatory activity in schizophrenia, bipolar disorder, and genetically high risk individuals under steady state response F1000research. 2. DOI: 10.7490/F1000Research.1658.1 |
0.413 |
|
| 2011 |
Lener MS, Talkowski ME, Wood J, Chukwu WJ, Keshavan MS, Nimgaonkar VL, Prasad KM. Brain structural evidence of epistasis between RGS4 & COMT variations in schizophrenia F1000research. 2. DOI: 10.7490/F1000Research.1417.1 |
0.316 |
|
| 2011 |
Mehta U, Bhagyavathi H, Thirthalli J, Naveen Kumar C, Subbakrishna D, Keshav Kumar J, Keshavan M, Gangadhar B. Factor structure of social cognition in remitted schizophrenia patients International Clinical Psychopharmacology. 26: e147. DOI: 10.1097/01.yic.0000405884.32956.37 |
0.314 |
|
| 2011 |
Tandon R, Nasrallah HA, Keshavan M. Antipsychotics, mortality and schizophrenia: What are the facts? Schizophrenia Research. 133: 262-263. DOI: 10.1016/J.Schres.2011.08.020 |
0.388 |
|
| 2010 |
Pareek P, Bhojraj TS, Montrose DM, Rajarethinam R, Sweeney JA, Keshavan MS. Involuntary movements and their correlates in first-episode psychoses. Acta Neuropsychiatrica. 22: 262-263. PMID 21892250 DOI: 10.1111/J.1601-5215.2010.00484.X |
0.343 |
|
| 2010 |
Eack SM, Greenwald DP, Hogarty SS, Keshavan MS. One-year durability of the effects of cognitive enhancement therapy on functional outcome in early schizophrenia. Schizophrenia Research. 120: 210-6. PMID 20472402 DOI: 10.1016/J.Schres.2010.03.042 |
0.344 |
|
| 2010 |
Eack SM, Hogarty GE, Cho RY, Prasad KM, Greenwald DP, Hogarty SS, Keshavan MS. Neuroprotective effects of cognitive enhancement therapy against gray matter loss in early schizophrenia: results from a 2-year randomized controlled trial. Archives of General Psychiatry. 67: 674-82. PMID 20439824 DOI: 10.1001/Archgenpsychiatry.2010.63 |
0.332 |
|
| 2010 |
Venkatasubramanian G, Jayakumar PN, Reddy VV, Reddy US, Gangadhar BN, Keshavan MS. Corpus callosum deficits in antipsychotic-naïve schizophrenia: Evidence for neurodevelopmental pathogenesis Psychiatry Research - Neuroimaging. 182: 141-145. PMID 20413279 DOI: 10.1016/j.pscychresns.2010.01.004 |
0.385 |
|
| 2010 |
Keshavan MS, Kulkarni S, Bhojraj T, Francis A, Diwadkar V, Montrose DM, Seidman LJ, Sweeney J. Premorbid cognitive deficits in young relatives of schizophrenia patients. Frontiers in Human Neuroscience. 3: 62. PMID 20300465 DOI: 10.3389/Neuro.09.062.2009 |
0.36 |
|
| 2010 |
Jayakumar PN, Gangadhar BN, Venkatasubramanian G, Desai S, Velayudhan L, Subbakrishna D, Keshavan MS. High energy phosphate abnormalities normalize after antipsychotic treatment in schizophrenia: A longitudinal 31P MRS study of basal ganglia Psychiatry Research - Neuroimaging. 181: 237-240. PMID 20153149 DOI: 10.1016/j.pscychresns.2009.10.010 |
0.308 |
|
| 2010 |
Bhojraj TS, Diwadkar VA, Sweeney JA, Prasad KM, Eack SM, Montrose DM, Keshavan MS. Longitudinal alterations of executive function in non-psychotic adolescents at familial risk for schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 34: 469-74. PMID 20117163 DOI: 10.1016/J.Pnpbp.2010.01.015 |
0.301 |
|
| 2010 |
Jindal RD, Pillai AK, Mahadik SP, Eklund K, Montrose DM, Keshavan MS. Decreased BDNF in patients with antipsychotic naïve first episode schizophrenia. Schizophrenia Research. 119: 47-51. PMID 20096541 DOI: 10.1016/j.schres.2009.12.035 |
0.347 |
|
| 2010 |
Siegle GJ, Condray R, Thase ME, Keshavan M, Steinhauer SR. Sustained gamma-band EEG following negative words in depression and schizophrenia. International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology. 75: 107-18. PMID 20005267 DOI: 10.1016/J.Ijpsycho.2008.04.008 |
0.366 |
|
| 2010 |
Shashi V, Kwapil TR, Kaczorowski J, Berry MN, Santos CS, Howard TD, Goradia D, Prasad K, Vaibhav D, Rajarethinam R, Spence E, Keshavan MS. Evidence of gray matter reduction and dysfunction in chromosome 22q11.2 deletion syndrome. Psychiatry Research. 181: 1-8. PMID 19962860 DOI: 10.1016/J.Pscychresns.2009.07.003 |
0.345 |
|
| 2010 |
Prasad KM, Goradia D, Eack S, Rajagopalan M, Nutche J, Magge T, Rajarethinam R, Keshavan MS. Cortical surface characteristics among offspring of schizophrenia subjects. Schizophrenia Research. 116: 143-51. PMID 19962858 DOI: 10.1016/J.Schres.2009.11.003 |
0.308 |
|
| 2010 |
Gilbert AM, Prasad K, Goradia D, Nutche J, Keshavan M, Frank E. Grey matter volume reductions in the emotion network of patients with depression and coronary artery disease. Psychiatry Research. 181: 9-14. PMID 19959343 DOI: 10.1016/J.Pscychresns.2009.07.006 |
0.313 |
|
| 2010 |
Lencer R, Reilly JL, Harris MS, Sprenger A, Keshavan MS, Sweeney JA. Sensorimotor transformation deficits for smooth pursuit in first-episode affective psychoses and schizophrenia. Biological Psychiatry. 67: 217-23. PMID 19782964 DOI: 10.1016/J.Biopsych.2009.08.005 |
0.349 |
|
| 2010 |
Eack SM, Mermon DE, Montrose DM, Miewald J, Gur RE, Gur RC, Sweeney JA, Keshavan MS. Social cognition deficits among individuals at familial high risk for schizophrenia. Schizophrenia Bulletin. 36: 1081-8. PMID 19366983 DOI: 10.1093/Schbul/Sbp026 |
0.311 |
|
| 2010 |
Eack SM, Greeno CG, Pogue-Geile MF, Newhill CE, Hogarty GE, Keshavan MS. Assessing social-cognitive deficits in schizophrenia with the Mayer-Salovey-Caruso Emotional Intelligence Test. Schizophrenia Bulletin. 36: 370-80. PMID 18648021 DOI: 10.1093/Schbul/Sbn091 |
0.346 |
|
| 2010 |
Wittmann D, Smith P, Rajarethinam RP, Foley S, VanBrussel A, Phillip B, Keshavan M. Do Patients With Psychosis Experience Loss and Grief As a Result of Their Illness Psychoanalytic Social Work. 17: 30-39. DOI: 10.1080/15228871003676622 |
0.304 |
|
| 2010 |
Prasad K, Eack S, Goradia D, Pancholi K, Keshavan M, Yolken R, Nimgaonkar V. Progressive grey matter loss and temporal changes in cognitive functions associated with exposure to HSV1 in schizophrenia: A longitudinal study Brain, Behavior, and Immunity. 24: S58. DOI: 10.1016/J.Bbi.2010.07.193 |
0.32 |
|
| 2009 |
Kumra S, Asarnow R, Grace A, Keshavan M, McClellan J, Sikich L, Wagner A. From bench to bedside: translating new research from genetics and neuroimaging into treatment development for early-onset schizophrenia. Early Intervention in Psychiatry. 3: 243-58. PMID 22642727 DOI: 10.1111/J.1751-7893.2009.00142.X |
0.458 |
|
| 2009 |
Keshavan MS, Eack SM, Montrose DM, Abela MM, Bangalore SS, Diwadkar VA, Prasad KM. Do premorbid impairments predict emergent 'prodromal' symptoms in young relatives at risk for schizophrenia? Early Intervention in Psychiatry. 3: 213-20. PMID 22640385 DOI: 10.1111/J.1751-7893.2009.00135.X |
0.308 |
|
| 2009 |
Harris MS, Reilly JL, Thase ME, Keshavan MS, Sweeney JA. Response suppression deficits in treatment-naïve first-episode patients with schizophrenia, psychotic bipolar disorder and psychotic major depression. Psychiatry Research. 170: 150-6. PMID 19906441 DOI: 10.1016/J.Psychres.2008.10.031 |
0.374 |
|
| 2009 |
Eack SM, Greenwald DP, Hogarty SS, Cooley SJ, DiBarry AL, Montrose DM, Keshavan MS. Cognitive enhancement therapy for early-course schizophrenia: effects of a two-year randomized controlled trial. Psychiatric Services (Washington, D.C.). 60: 1468-76. PMID 19880464 DOI: 10.1176/appi.ps.60.11.1468 |
0.317 |
|
| 2009 |
Bhojraj TS, Francis AN, Rajarethinam R, Eack S, Kulkarni S, Prasad KM, Montrose DM, Dworakowski D, Diwadkar V, Keshavan MS. Verbal fluency deficits and altered lateralization of language brain areas in individuals genetically predisposed to schizophrenia. Schizophrenia Research. 115: 202-8. PMID 19840895 DOI: 10.1016/J.Schres.2009.09.033 |
0.305 |
|
| 2009 |
Mansour HA, Talkowski ME, Wood J, Chowdari KV, McClain L, Prasad K, Montrose D, Fagiolini A, Friedman ES, Allen MH, Bowden CL, Calabrese J, El-Mallakh RS, Escamilla M, Faraone SV, ... ... Keshavan M, et al. Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia. Bipolar Disorders. 11: 701-10. PMID 19839995 DOI: 10.1111/J.1399-5618.2009.00756.X |
0.368 |
|
| 2009 |
Keshavan MS, Dick RM, Diwadkar VA, Montrose DM, Prasad KM, Stanley JA. Striatal metabolic alterations in non-psychotic adolescent offspring at risk for schizophrenia: a (1)H spectroscopy study. Schizophrenia Research. 115: 88-93. PMID 19748228 DOI: 10.1016/J.Schres.2009.08.012 |
0.319 |
|
| 2009 |
Boutros NN, Brockhaus-Dumke A, Gjini K, Vedeniapin A, Elfakhani M, Burroughs S, Keshavan M. Sensory-gating deficit of the N100 mid-latency auditory evoked potential in medicated schizophrenia patients Schizophrenia Research. 113: 339-346. PMID 19524407 DOI: 10.1016/J.Schres.2009.05.019 |
0.435 |
|
| 2009 |
Eack SM, Pogue-Geile MF, Greeno CG, Keshavan MS. Evidence of factorial variance of the Mayer-Salovey-Caruso Emotional Intelligence Test across schizophrenia and normative samples. Schizophrenia Research. 114: 105-9. PMID 19501486 DOI: 10.1016/J.Schres.2009.05.011 |
0.316 |
|
| 2009 |
Rajarethinam R, Dziuba J, Manji S, Pizzuti A, Lachover L, Keshavan M. Use of aripiprazole in tardive dyskinesia: an open label study of six cases. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 10: 416-9. PMID 19492247 DOI: 10.1080/15622970902995612 |
0.366 |
|
| 2009 |
Bangalore SS, Goradia DD, Nutche J, Diwadkar VA, Prasad KM, Keshavan MS. Untreated illness duration correlates with gray matter loss in first-episode psychoses. Neuroreport. 20: 729-34. PMID 19349913 DOI: 10.1097/WNR.0b013e32832ae501 |
0.367 |
|
| 2009 |
Tandon R, Nasrallah HA, Keshavan MS. Schizophrenia, "just the facts" 4. Clinical features and conceptualization. Schizophrenia Research. 110: 1-23. PMID 19328655 DOI: 10.1016/j.schres.2009.03.005 |
0.373 |
|
| 2009 |
Nasrallah HA, Keshavan MS, Benes FM, Braff DL, Green AI, Gur RE, Kane JM, Perkins DO, Weiden PJ, Weinberger DR, Correll CU. Proceedings and data from The Schizophrenia Summit: a critical appraisal to improve the management of Schizophrenia. The Journal of Clinical Psychiatry. 70: 4-46. PMID 19292973 DOI: 10.4088/JCP.8157su1c.01 |
0.349 |
|
| 2009 |
Prasad KM, Sanders R, Sweeney J, Montrose D, Diwadkar V, Dworakowski D, Miewald J, Keshavan M. Neurological abnormalities among offspring of persons with schizophrenia: Relation to premorbid psychopathology Schizophrenia Research. 108: 163-169. PMID 19108992 DOI: 10.1016/J.Schres.2008.11.019 |
0.458 |
|
| 2009 |
Keshavan MS, Diwadkar VA, Prasad K, Stanley JA. Neuroimaging of schizophrenia and its development Neuroimaging in Developmental Clinical Neuroscience. 147-160. DOI: 10.1017/CBO9780511757402.013 |
0.321 |
|
| 2008 |
Stanley JA, Kipp H, Greisenegger E, MacMaster FP, Panchalingam K, Keshavan MS, Bukstein OG, Pettegrew JW. Evidence of developmental alterations in cortical and subcortical regions of children with attention-deficit/hyperactivity disorder: a multivoxel in vivo phosphorus 31 spectroscopy study. Archives of General Psychiatry. 65: 1419-28. PMID 19047529 DOI: 10.1001/Archgenpsychiatry.2008.503 |
0.554 |
|
| 2008 |
Venkatasubramanian G, Jayakumar PN, Gangadhar BN, Keshavan MS. Neuroanatomical correlates of neurological soft signs in antipsychotic-naive schizophrenia Psychiatry Research - Neuroimaging. 164: 215-222. PMID 19019637 DOI: 10.1016/j.pscychresns.2007.12.021 |
0.365 |
|
| 2008 |
Paus T, Keshavan M, Giedd JN. Why do many psychiatric disorders emerge during adolescence? Nature Reviews. Neuroscience. 9: 947-57. PMID 19002191 DOI: 10.1038/Nrn2513 |
0.318 |
|
| 2008 |
Keshavan MS, Tandon R, Boutros NN, Nasrallah HA. Schizophrenia, "just the facts": what we know in 2008 Part 3: neurobiology. Schizophrenia Research. 106: 89-107. PMID 18799287 DOI: 10.1016/j.schres.2008.07.020 |
0.326 |
|
| 2008 |
Eack SM, George MM, Prasad KM, Keshavan MS. Neuroanatomical substrates of foresight in schizophrenia. Schizophrenia Research. 103: 62-70. PMID 18603414 DOI: 10.1016/J.Schres.2008.05.012 |
0.397 |
|
| 2008 |
Jindal RD, Keshavan MS. Neurobiology of the early course of schizophrenia. Expert Review of Neurotherapeutics. 8: 1093-100. PMID 18590479 DOI: 10.1586/14737175.8.7.1093 |
0.355 |
|
| 2008 |
Tandon R, Keshavan MS, Nasrallah HA. Schizophrenia, "just the facts" what we know in 2008. 2. Epidemiology and etiology. Schizophrenia Research. 102: 1-18. PMID 18514488 DOI: 10.1016/j.schres.2008.04.011 |
0.317 |
|
| 2008 |
Venkatasubramanian G, Jayakumar PN, Gangadhar BN, Keshavan MS. Automated MRI parcellation study of regional volume and thickness of prefrontal cortex (PFC) in antipsychotic-naïve schizophrenia Acta Psychiatrica Scandinavica. 117: 420-431. PMID 18479318 DOI: 10.1111/j.1600-0447.2008.01198.x |
0.373 |
|
| 2008 |
Keshavan M, Montrose DM, Rajarethinam R, Diwadkar V, Prasad K, Sweeney JA. Psychopathology among offspring of parents with schizophrenia: relationship to premorbid impairments. Schizophrenia Research. 103: 114-20. PMID 18442896 DOI: 10.1016/J.Schres.2008.03.006 |
0.471 |
|
| 2008 |
Prasad KM, Keshavan MS. Structural cerebral variations as useful endophenotypes in schizophrenia: do they help construct "extended endophenotypes"? Schizophrenia Bulletin. 34: 774-90. PMID 18408230 DOI: 10.1093/schbul/sbn017 |
0.381 |
|
| 2008 |
Meda SA, Giuliani NR, Calhoun VD, Jagannathan K, Schretlen DJ, Pulver A, Cascella N, Keshavan M, Kates W, Buchanan R, Sharma T, Pearlson GD. A large scale (N=400) investigation of gray matter differences in schizophrenia using optimized voxel-based morphometry. Schizophrenia Research. 101: 95-105. PMID 18378428 DOI: 10.1016/J.Schres.2008.02.007 |
0.462 |
|
| 2008 |
Gilbert AR, Keshavan MS, Diwadkar V, Nutche J, Macmaster F, Easter PC, Buhagiar CJ, Rosenberg DR. Gray matter differences between pediatric obsessive-compulsive disorder patients and high-risk siblings: a preliminary voxel-based morphometry study. Neuroscience Letters. 435: 45-50. PMID 18314272 DOI: 10.1016/J.Neulet.2008.02.011 |
0.696 |
|
| 2008 |
Tandon R, Keshavan MS, Nasrallah HA. Schizophrenia, "Just the Facts": what we know in 2008 part 1: overview. Schizophrenia Research. 100: 4-19. PMID 18291627 DOI: 10.1016/j.schres.2008.01.022 |
0.341 |
|
| 2008 |
Rajarethinam R, Sohi J, Arfken C, Keshavan MS. No difference in the prevalence of cavum septum pellucidum (CSP) between first-episode schizophrenia patients, offspring of schizophrenia patients and healthy controls. Schizophrenia Research. 103: 22-5. PMID 18248791 DOI: 10.1016/j.schres.2007.11.031 |
0.327 |
|
| 2008 |
Mamo D, Kapur S, Keshavan M, Laruelle M, Taylor CC, Kothare PA, Barsoum P, McDonnell D. D2 receptor occupancy of olanzapine pamoate depot using positron emission tomography: an open-label study in patients with schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 298-304. PMID 17443131 DOI: 10.1038/Sj.Npp.1301409 |
0.314 |
|
| 2008 |
Yao J, Dougherty G, Reddy R, Keshavan M, Montrose D, Matson W, Rozen S, McEvoy J, Kaddurah-Daouk R. Multivariate Comparisons Of Plasma Monoamine Metabolites In Healthy Controls And First-Episode Neuroleptic-Naïve Patients With Schizophrenia Schizophrenia Research. 102: 210. DOI: 10.1016/S0920-9964(08)70634-0 |
0.404 |
|
| 2008 |
Yao J, Dougherty G, Keshavan M, Montrose D, Matson W, Rozen S, McEvoy J, Kaddurah-Daouk R, Reddy R. Abnormal Purine Catabolism In First-Episode Neuroleptic-Naïve Patients With Schizophrenia Schizophrenia Research. 102: 209-210. DOI: 10.1016/S0920-9964(08)70633-9 |
0.435 |
|
| 2008 |
Nelson B, McGorry P, Yung A, Amminger P, Francey S, Berk M, Klosterkoetter J, Schultze-Lutter F, Stephan R, Bechdolf A, McGuire P, Keshavan M, Hickie I, Riecher-Rössler A, Chen E, et al. The Neurapro (North America, Europe, Australia Prodrome) Study: A Multicenter Rct Of Treatment Strategies For Symptomatic Patients At Ultra-High Risk For Progression To Schizophrenia And Related Disorders. Design And Study Plan Schizophrenia Research. 102: 155. DOI: 10.1016/S0920-9964(08)70470-5 |
0.418 |
|
| 2008 |
Diwadkar V, Murphy E, Keshavan M, Erdi P. REDUCED HIPPOCAMPAL-CORTICAL CONNECTIVITY IN SCHIZOPHRENIA DURING ASSOCIATIVE LEARNING: fMRI STUDIES AND IMPLICATIONS FOR PHARMACOLOGY Schizophrenia Research. 102: 85. DOI: 10.1016/S0920-9964(08)70259-7 |
0.409 |
|
| 2007 |
Keshavan MS, Amirsadri A. Early intervention in schizophrenia: current and future perspectives. Current Psychiatry Reports. 9: 325-8. PMID 17880865 DOI: 10.1007/S11920-007-0040-8 |
0.316 |
|
| 2007 |
Rajarethinam R, Upadhyaya A, Tsou P, Upadhyaya M, Keshavan MS. Caudate volume in offspring of patients with schizophrenia. The British Journal of Psychiatry : the Journal of Mental Science. 191: 258-9. PMID 17766768 DOI: 10.1192/bjp.bp.106.029017 |
0.35 |
|
| 2007 |
Shad MU, Keshavan MS, Tamminga CA, Cullum CM, David A. Neurobiological underpinnings of insight deficits in schizophrenia. International Review of Psychiatry (Abingdon, England). 19: 437-46. PMID 17671876 DOI: 10.1080/09540260701486324 |
0.339 |
|
| 2007 |
Keshavan MS, Prasad KM, Pearlson G. Are brain structural abnormalities useful as endophenotypes in schizophrenia? International Review of Psychiatry (Abingdon, England). 19: 397-406. PMID 17671872 DOI: 10.1080/09540260701486233 |
0.368 |
|
| 2007 |
Wittmann D, Keshavan M. Grief and mourning in schizophrenia. Psychiatry. 70: 154-66. PMID 17661540 DOI: 10.1521/Psyc.2007.70.2.154 |
0.388 |
|
| 2007 |
Gur RE, Keshavan MS, Lawrie SM. Deconstructing psychosis with human brain imaging. Schizophrenia Bulletin. 33: 921-31. PMID 17548845 DOI: 10.1093/schbul/sbm045 |
0.395 |
|
| 2007 |
Stanley JA, Vemulapalli M, Nutche J, Montrose DM, Sweeney JA, Pettegrew JW, MacMaster FP, Keshavan MS. Reduced N-acetyl-aspartate levels in schizophrenia patients with a younger onset age: a single-voxel 1H spectroscopy study. Schizophrenia Research. 93: 23-32. PMID 17498928 DOI: 10.1016/J.Schres.2007.03.028 |
0.584 |
|
| 2007 |
Strassnig M, Miewald J, Keshavan M, Ganguli R. Weight gain in newly diagnosed first-episode psychosis patients and healthy comparisons: One-year analysis Schizophrenia Research. 93: 90-98. PMID 17478082 DOI: 10.1016/J.Schres.2007.02.024 |
0.304 |
|
| 2007 |
MacMaster FP, El-Sheikh R, Upadhyaya AR, Nutche J, Rosenberg DR, Keshavan M. Effect of antipsychotics on pituitary gland volume in treatment-naïve first-episode schizophrenia: a pilot study. Schizophrenia Research. 92: 207-10. PMID 17337162 DOI: 10.1016/J.Schres.2007.01.022 |
0.723 |
|
| 2007 |
Lacerda AL, Hardan AY, Yorbik O, Vemulapalli M, Prasad KM, Keshavan MS. Morphology of the orbitofrontal cortex in first-episode schizophrenia: relationship with negative symptomatology. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 31: 510-6. PMID 17239513 DOI: 10.1016/j.pnpbp.2006.11.022 |
0.364 |
|
| 2007 |
Reddy R, Keshavan M, Yao JK. Blunted serotonergic responsivity in neuroleptic-naïve patients at first-episode of schizophrenia. Schizophrenia Research. 90: 81-5. PMID 17204398 DOI: 10.1016/J.Schres.2006.11.013 |
0.378 |
|
| 2007 |
Upadhyaya AR, El-Sheikh R, MacMaster FP, Diwadkar VA, Keshavan MS. Pituitary volume in neuroleptic-naïve schizophrenia: a structural MRI study. Schizophrenia Research. 90: 266-73. PMID 17187962 DOI: 10.1016/J.Schres.2006.09.033 |
0.612 |
|
| 2007 |
MacMaster FP, Keshavan M, Mirza Y, Carrey N, Upadhyaya AR, El-Sheikh R, Buhagiar CJ, Taormina SP, Boyd C, Lynch M, Rose M, Ivey J, Moore GJ, Rosenberg DR. Development and sexual dimorphism of the pituitary gland. Life Sciences. 80: 940-4. PMID 17174342 DOI: 10.1016/J.Lfs.2006.11.040 |
0.658 |
|
| 2007 |
Eack SM, Hogarty GE, Greenwald DP, Hogarty SS, Keshavan MS. Cognitive enhancement therapy improves emotional intelligence in early course schizophrenia: preliminary effects. Schizophrenia Research. 89: 308-11. PMID 17055227 DOI: 10.1016/J.Schres.2006.08.018 |
0.315 |
|
| 2007 |
Prasad KM, Shirts BH, Yolken RH, Keshavan MS, Nimgaonkar VL. Brain morphological changes associated with exposure to HSV1 in first-episode schizophrenia. Molecular Psychiatry. 12: 105-13, 1. PMID 17033628 DOI: 10.1038/Sj.Mp.4001915 |
0.34 |
|
| 2007 |
Hill SY, Muddasani S, Prasad K, Nutche J, Steinhauer SR, Scanlon J, McDermott M, Keshavan M. Cerebellar volume in offspring from multiplex alcohol dependence families. Biological Psychiatry. 61: 41-7. PMID 16533498 DOI: 10.1016/J.Biopsych.2006.01.007 |
0.319 |
|
| 2007 |
Prasad KMR, Shirts BH, Yolken RH, Keshavan MS, Nimgaonkar VL. HSV1 exposure affects prefrontal cortical structure in schizophrenia patients Molecular Psychiatry. 12: 1. DOI: 10.1038/Sj.Mp.4001942 |
0.313 |
|
| 2006 |
Stanley JA, Kipp H, Greisenegger E, MacMaster FP, Panchalingam K, Pettegrew JW, Keshavan MS, Bukstein OG. Regionally specific alterations in membrane phospholipids in children with ADHD: An in vivo 31P spectroscopy study. Psychiatry Research. 148: 217-21. PMID 17095197 DOI: 10.1016/J.Pscychresns.2006.08.003 |
0.507 |
|
| 2006 |
Jayakumar PN, Venkatasubramanian G, Keshavan MS, Srinivas JS, Gangadhar BN. MRI volumetric and 31P MRS metabolic correlates of caudate nucleus in antipsychotic-naïve schizophrenia Acta Psychiatrica Scandinavica. 114: 346-351. PMID 17022794 DOI: 10.1111/j.1600-0447.2006.00836.x |
0.315 |
|
| 2006 |
MacMaster FP, Russell A, Mirza Y, Keshavan MS, Taormina SP, Bhandari R, Boyd C, Lynch M, Rose M, Ivey J, Moore GJ, Rosenberg DR. Pituitary volume in treatment-naïve pediatric major depressive disorder. Biological Psychiatry. 60: 862-6. PMID 16876142 DOI: 10.1016/J.Biopsych.2006.04.013 |
0.679 |
|
| 2006 |
Shad MU, Tamminga CA, Cullum M, Haas GL, Keshavan MS. Insight and frontal cortical function in schizophrenia: a review. Schizophrenia Research. 86: 54-70. PMID 16837168 DOI: 10.1016/J.Schres.2006.06.006 |
0.353 |
|
| 2006 |
Monkul ES, Nicoletti MA, Spence D, Sassi RB, Axelson D, Brambilla P, Hatch JP, Keshavan M, Ryan N, Birmaher B, Soares JC. MRI study of thalamus volumes in juvenile patients with bipolar disorder. Depression and Anxiety. 23: 347-352. PMID 16688738 DOI: 10.1002/Da.20161 |
0.436 |
|
| 2006 |
Gangadhar BN, Jayakumar PN, Venkatasubramanian G, Janakiramaiah N, Keshavan MS. Developmental reflexes and 31P Magnetic Resonance Spectroscopy of basal ganglia in antipsychotic-naive schizophrenia Progress in Neuro-Psychopharmacology and Biological Psychiatry. 30: 910-913. PMID 16569471 DOI: 10.1016/j.pnpbp.2006.02.003 |
0.316 |
|
| 2006 |
Harris MS, Reilly JL, Keshavan MS, Sweeney JA. Longitudinal studies of antisaccades in antipsychotic-naive first-episode schizophrenia. Psychological Medicine. 36: 485-94. PMID 16388703 DOI: 10.1017/S0033291705006756 |
0.339 |
|
| 2006 |
Yasar AS, Monkul ES, Sassi RB, Axelson D, Brambilla P, Nicoletti MA, Hatch JP, Keshavan M, Ryan N, Birmaher B, Soares JC. MRI study of corpus callosum in children and adolescents with bipolar disorder. Psychiatry Research-Neuroimaging. 146: 83-85. PMID 16337778 DOI: 10.1016/J.Pscychresns.2005.09.004 |
0.377 |
|
| 2006 |
Diwadkar VA, Montrose DM, Dworakowski D, Sweeney JA, Keshavan MS. Genetically predisposed offspring with schizotypal features: an ultra high-risk group for schizophrenia? Progress in Neuro-Psychopharmacology & Biological Psychiatry. 30: 230-8. PMID 16318899 DOI: 10.1016/J.Pnpbp.2005.10.019 |
0.35 |
|
| 2006 |
MacMaster FP, Russell A, Mirza Y, Keshavan MS, Banerjee SP, Bhandari R, Boyd C, Lynch M, Rose M, Ivey J, Moore GJ, Rosenberg DR. Pituitary volume in pediatric obsessive-compulsive disorder. Biological Psychiatry. 59: 252-7. PMID 16140279 DOI: 10.1016/J.Biopsych.2005.06.028 |
0.691 |
|
| 2006 |
Wittmann D, Keshavan M. 0067 GRIEF AND MOURNING IN SCHIZOPHRENIA Schizophrenia Research. 86: S136. DOI: 10.1016/S0920-9964(06)70408-X |
0.311 |
|
| 2006 |
Prasad K, Diwadkar V, Nutche J, Hogarty G, Keshavan M. 0465 A COMPARATIVE FOLLOW UP STUDY OF CORTICAL GREY MATTER CHANGES ASSOCIATED WITH TWO TYPES OF THERAPY IN EARLY COURSE SCHIZOPHRENIA PATIENTS Schizophrenia Research. 86: S77. DOI: 10.1016/S0920-9964(06)70228-6 |
0.416 |
|
| 2005 |
Keshavan MS, Diwadkar V, Rosenberg DR. Developmental biomarkers in schizophrenia and other psychiatric disorders: common origins, different trajectories? Epidemiologia E Psichiatria Sociale. 14: 188-93. PMID 16396426 DOI: 10.1017/S1121189X00007934 |
0.609 |
|
| 2005 |
Shad MU, Muddasani S, Keshavan MS. Prefrontal subregions and dimensions of insight in first-episode schizophrenia--a pilot study. Psychiatry Research. 146: 35-42. PMID 16361089 DOI: 10.1016/j.pscychresns.2005.11.001 |
0.345 |
|
| 2005 |
Prasad KM, Sahni SD, Rohm BR, Keshavan MS. Dorsolateral prefrontal cortex morphology and short-term outcome in first-episode schizophrenia. Psychiatry Research. 140: 147-55. PMID 16256315 DOI: 10.1016/j.pscychresns.2004.05.009 |
0.33 |
|
| 2005 |
Keshavan MS, Diwadkar VA, Montrose DM, Rajarethinam R, Sweeney JA. Premorbid indicators and risk for schizophrenia: a selective review and update. Schizophrenia Research. 79: 45-57. PMID 16139479 DOI: 10.1016/J.Schres.2005.07.004 |
0.328 |
|
| 2005 |
Keshavan MS, Berger G, Zipursky RB, Wood SJ, Pantelis C. Neurobiology of early psychosis. The British Journal of Psychiatry. Supplement. 48: s8-18. PMID 16055814 DOI: 10.1192/bjp.187.48.s8 |
0.308 |
|
| 2005 |
Jou RJ, Hardan AY, Keshavan MS. Reduced cortical folding in individuals at high risk for schizophrenia: a pilot study. Schizophrenia Research. 75: 309-13. PMID 15885522 DOI: 10.1016/J.Schres.2004.11.008 |
0.331 |
|
| 2005 |
Jayakumar PN, Venkatasubramanian G, Gangadhar BN, Janakiramaiah N, Keshavan MS. Optimized voxel-based morphometry of gray matter volume in first-episode, antipsychotic-naïve schizophrenia Progress in Neuro-Psychopharmacology and Biological Psychiatry. 29: 587-591. PMID 15866362 DOI: 10.1016/j.pnpbp.2005.01.020 |
0.359 |
|
| 2005 |
Duggal HS, Muddasani S, Keshavan MS. Insular volumes in first-episode schizophrenia: gender effect. Schizophrenia Research. 73: 113-20. PMID 15567083 DOI: 10.1016/j.schres.2004.08.027 |
0.345 |
|
| 2005 |
Prasad KM, Chowdari KV, Nimgaonkar VL, Talkowski ME, Lewis DA, Keshavan MS. Genetic polymorphisms of the RGS4 and dorsolateral prefrontal cortex morphometry among first episode schizophrenia patients. Molecular Psychiatry. 10: 213-9. PMID 15381923 DOI: 10.1038/Sj.Mp.4001562 |
0.346 |
|
| 2005 |
Keshavan MS, MacMaster F. A Review of: “Clinical MR Neuroimaging. Diffusion, Perfusion and Spectroscopy. Edited by Jonathan Gillard, Adam Waldman and Peter Barker” Annals of Clinical Psychiatry. 17: 190-190. DOI: 10.1080/10401230500343485 |
0.438 |
|
| 2005 |
Rajarethinam R, Prasad K, Keshavan MS. The nature of brain abnormalities in schizophrenia: What do we really know? Current Psychosis & Therapeutics Reports. 3: 48-52. DOI: 10.1007/BF02629421 |
0.318 |
|
| 2004 |
Keshavan MS, Diwadkar VA, Montrose DM, Stanley JA, Pettegrew JW. Premorbid characterization in schizophrenia: the Pittsburgh High Risk Study. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 3: 163-8. PMID 16633488 |
0.303 |
|
| 2004 |
Schuepbach D, Hill SK, Sanders RD, Hell D, Keshavan MS, Sweeney JA. Early treatment-induced improvement of negative symptoms predicts cognitive functioning in treatment-naive first episode schizophrenia: a 2-year followup. Schizophrenia Bulletin. 30: 837-48. PMID 15957199 DOI: 10.1093/Oxfordjournals.Schbul.A007136 |
0.351 |
|
| 2004 |
Sassi RB, Brambilla P, Hatch JP, Nicoletti MA, Mallinger AG, Frank E, Kupfer DJ, Keshavan MS, Soares JC. Reduced left anterior cingulate volumes in untreated bipolar patients. Biological Psychiatry. 56: 467-75. PMID 15450781 DOI: 10.1016/J.Biopsych.2004.07.005 |
0.324 |
|
| 2004 |
Keshavan M, Shad M, Soloff P, Schooler N. Efficacy and tolerability of olanzapine in the treatment of schizotypal personality disorder Schizophrenia Research. 71: 97-101. PMID 15374577 DOI: 10.1016/J.Schres.2003.12.008 |
0.362 |
|
| 2004 |
Keshavan MS, Rabinowitz J, DeSmedt G, Harvey PD, Schooler N. Correlates of insight in first episode psychosis. Schizophrenia Research. 70: 187-94. PMID 15329295 DOI: 10.1016/j.schres.2003.11.007 |
0.364 |
|
| 2004 |
Prasad KM, Rohm BR, Keshavan MS. Parahippocampal gyrus in first episode psychotic disorders: a structural magnetic resonance imaging study. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 28: 651-8. PMID 15276690 DOI: 10.1016/j.pnpbp.2004.01.017 |
0.377 |
|
| 2004 |
Diwadkar VA, Prasad KM, Keshavan MS. Approaches for adolescents with an affected family member with schizophrenia. Current Psychiatry Reports. 6: 296-302. PMID 15260946 |
0.304 |
|
| 2004 |
Gangadhar BN, Jayakumar PN, Subbakrishna DK, Janakiramaiah N, Keshavan MS. Basal ganglia high-energy phosphate metabolism in neuroleptic-naive patients with schizophrenia: A 31-phosphorus magnetic resonance spectroscopic study American Journal of Psychiatry. 161: 1304-1306. PMID 15229069 DOI: 10.1176/appi.ajp.161.7.1304 |
0.309 |
|
| 2004 |
Shad MU, Muddasani S, Prasad K, Sweeney JA, Keshavan MS. Insight and prefrontal cortex in first-episode Schizophrenia. Neuroimage. 22: 1315-20. PMID 15219603 DOI: 10.1016/J.Neuroimage.2004.03.016 |
0.381 |
|
| 2004 |
Shashi V, Muddasani S, Santos CC, Berry MN, Kwapil TR, Lewandowski E, Keshavan MS. Abnormalities of the corpus callosum in nonpsychotic children with chromosome 22q11 deletion syndrome. Neuroimage. 21: 1399-406. PMID 15050565 DOI: 10.1016/J.Neuroimage.2003.12.004 |
0.302 |
|
| 2004 |
Hill SK, Schuepbach D, Herbener ES, Keshavan MS, Sweeney JA. Pretreatment and longitudinal studies of neuropsychological deficits in antipsychotic-naïve patients with schizophrenia. Schizophrenia Research. 68: 49-63. PMID 15037339 DOI: 10.1016/S0920-9964(03)00213-5 |
0.337 |
|
| 2004 |
Diwadkar VA, DeBellis MD, Sweeney JA, Pettegrew JW, Keshavan MS. Abnormalities in MRI-measured signal intensity in the corpus callosum in schizophrenia. Schizophrenia Research. 67: 277-82. PMID 14984888 DOI: 10.1016/S0920-9964(03)00098-7 |
0.341 |
|
| 2003 |
Seidman LJ, Pantelis C, Keshavan MS, Faraone SV, Goldstein JM, Horton NJ, Makris N, Falkai P, Caviness VS, Tsuang MT. A review and new report of medial temporal lobe dysfunction as a vulnerability indicator for schizophrenia: a magnetic resonance imaging morphometric family study of the parahippocampal gyrus. Schizophrenia Bulletin. 29: 803-30. PMID 14989416 DOI: 10.1093/Oxfordjournals.Schbul.A007048 |
0.352 |
|
| 2003 |
Cannon TD, van Erp TG, Bearden CE, Loewy R, Thompson P, Toga AW, Huttunen MO, Keshavan MS, Seidman LJ, Tsuang MT. Early and late neurodevelopmental influences in the prodrome to schizophrenia: contributions of genes, environment, and their interactions. Schizophrenia Bulletin. 29: 653-69. PMID 14989405 DOI: 10.1093/Oxfordjournals.Schbul.A007037 |
0.329 |
|
| 2003 |
Jayakumar PN, Gangadhar BN, Subbakrishna DK, Janakiramaiah N, Srinivas JS, Keshavan MS. Membrane phospholipid abnormalities of basal ganglia in never-treated schizophrenia: A 31P magnetic resonance spectroscopy study Biological Psychiatry. 54: 491-494. PMID 12915294 DOI: 10.1016/S0006-3223(02)01829-2 |
0.337 |
|
| 2003 |
Reddy R, Keshavan M, Yao JK. Reduced plasma antioxidants in first-episode patients with schizophrenia. Schizophrenia Research. 62: 205-12. PMID 12837516 DOI: 10.1016/S0920-9964(02)00407-3 |
0.395 |
|
| 2003 |
Keshavan MS, Sanders RD, Sweeney JA, Diwadkar VA, Goldstein G, Pettegrew JW, Schooler NR. Diagnostic specificity and neuroanatomical validity of neurological abnormalities in first-episode psychoses. The American Journal of Psychiatry. 160: 1298-304. PMID 12832245 DOI: 10.1176/Appi.Ajp.160.7.1298 |
0.379 |
|
| 2003 |
Venkatasubramanian G, Latha V, Gangadhar BN, Janakiramaiah N, Subbakrishna DK, Jayakumar PN, Keshavan MS. Neurological soft signs in never-treated schizophrenia Acta Psychiatrica Scandinavica. 108: 144-146. PMID 12823171 DOI: 10.1034/j.1600-0447.2003.00113.x |
0.342 |
|
| 2003 |
Keshavan MS, Stanley JA, Montrose DM, Minshew NJ, Pettegrew JW. Prefrontal membrane phospholipid metabolism of child and adolescent offspring at risk for schizophrenia or schizoaffective disorder: an in vivo 31P MRS study. Molecular Psychiatry. 8: 316-23, 251. PMID 12660804 DOI: 10.1038/Sj.Mp.4001325 |
0.306 |
|
| 2003 |
Pettegrew J, Goldstein G, Keshavan M, Stanley J, Panchalingam K, McClure R. 31P MRS evidence of an association between cognitive impairment and membrane phospholipid alterations in chronic schizophrenia Schizophrenia Research. 60: 244-245. DOI: 10.1016/S0920-9964(03)81255-0 |
0.304 |
|
| 2003 |
Diwadkar V, Chaluvadi S, Sahni S, Sweeney J, Keshavan M. Gray matter changes in the early course of schizophrenia Schizophrenia Research. 60: 193. DOI: 10.1016/S0920-9964(03)81107-6 |
0.313 |
|
| 2003 |
Hill S, Keshavan M, Sweeney J. The relationship of psychosis to neuropsychological dysfunction in unmedicated first-episode schizophrenia, psychotic and non-psychotic unipolar depression, and healthy volunteers Schizophrenia Research. 60: 138-139. DOI: 10.1016/S0920-9964(03)80938-6 |
0.314 |
|
| 2003 |
Diwadkar VA, Keshavan MS. Emerging insights on the neuroanatomy of schizophrenia Current Psychosis & Therapeutics Reports. 1: 28-34. DOI: 10.1007/BF02629436 |
0.305 |
|
| 2002 |
Keshavan MS, Jayakumar PN, Diwadkar VA, Singh A. Cavum septi pellucidi in first-episode patients and young relatives at risk for schizophrenia. Cns Spectrums. 7: 155-8. PMID 15220858 |
0.324 |
|
| 2002 |
Keshavan MS, Dick E, Mankowski I, Harenski K, Montrose DM, Diwadkar V, DeBellis M. Decreased left amygdala and hippocampal volumes in young offspring at risk for schizophrenia Schizophrenia Research. 58: 173-183. PMID 12409156 DOI: 10.1016/S0920-9964(01)00404-2 |
0.335 |
|
| 2002 |
Keshavan MS, Diwadkar VA, Harenski K, Rosenberg DR, Sweeney JA, Pettegrew JW. Abnormalities of the corpus callosum in first episode, treatment naive schizophrenia. Journal of Neurology, Neurosurgery, and Psychiatry. 72: 757-60. PMID 12023420 DOI: 10.1136/Jnnp.72.6.757 |
0.624 |
|
| 2002 |
Keshavan MS, Diwadkar VA, DeBellis M, Dick E, Kotwal R, Rosenberg DR, Sweeney JA, Minshew N, Pettegrew JW. Development of the corpus callosum in childhood, adolescence and early adulthood. Life Sciences. 70: 1909-22. PMID 12005176 DOI: 10.1016/S0024-3205(02)01492-3 |
0.495 |
|
| 2002 |
Schuepbach D, Keshavan MS, Kmiec JA, Sweeney JA. Negative symptom resolution and improvements in specific cognitive deficits after acute treatment in first-episode schizophrenia. Schizophrenia Research. 53: 249-61. PMID 11738538 DOI: 10.1016/S0920-9964(01)00195-5 |
0.317 |
|
| 2001 |
Diwadkar VA, Sweeney JA, Boarts D, Montrose DM, Keshavan MS. Oculomotor delayed response abnormalities in young offspring and siblings at risk for schizophrenia. Cns Spectrums. 6: 899-903. PMID 15328471 DOI: 10.1017/S109285290000095X |
0.332 |
|
| 2001 |
Gilbert AR, Rosenberg DR, Harenski K, Spencer S, Sweeney JA, Keshavan MS. Thalamic volumes in patients with first-episode schizophrenia. The American Journal of Psychiatry. 158: 618-24. PMID 11282698 DOI: 10.1176/Appi.Ajp.158.4.618 |
0.619 |
|
| 2001 |
Gilbert AR, Keshavan MS. MRI structural findings in schizophrenia Revista Brasileira De Psiquiatria. 23: 15-18. DOI: 10.1590/S1516-44462001000500006 |
0.312 |
|
| 2000 |
Rosenberg DR, MacMaster FP, Keshavan MS, Fitzgerald KD, Stewart CM, Moore GJ. Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine. Journal of the American Academy of Child and Adolescent Psychiatry. 39: 1096-103. PMID 10986805 DOI: 10.1097/00004583-200009000-00008 |
0.673 |
|
| 2000 |
Gilbert AR, Moore GJ, Keshavan MS, Paulson LA, Narula V, Mac Master FP, Stewart CM, Rosenberg DR. Decrease in thalamic volumes of pediatric patients with obsessive-compulsive disorder who are taking paroxetine. Archives of General Psychiatry. 57: 449-56. PMID 10807485 DOI: 10.1001/Archpsyc.57.5.449 |
0.581 |
|
| 2000 |
Keshavan MS. Development, disease and degeneration in schizophrenia: a unitary pathophysiological model. Journal of Psychiatric Research. 33: 513-21. PMID 10628528 DOI: 10.1016/S0022-3956(99)00033-3 |
0.357 |
|
| 2000 |
Gilbert AR, Spencer S, Mankowski I, Ziegler MR, Montrose DM, Rosenberg DR, Keshavan MS. Thalamic volumes in first episode schizophrenic patients Schizophrenia Research. 41: 114. DOI: 10.1016/S0920-9964(00)90573-5 |
0.537 |
|
| 2000 |
Gilbert A, Spencer S, Mankowski I, Zeigler MR, Montrose DM, Harenski K, Rosenberg D, Keshavan MS. 352. Thalamic volumes in first episode schizophrenic patients Biological Psychiatry. 47. DOI: 10.1016/S0006-3223(00)00616-8 |
0.537 |
|
| 2000 |
Keshavan M, Harenski K, Peters B, Spencer S, Montrose D, Zeigler M, Radomsky E, McLaughlin N, Sweeney J. 351. MRI abnormalities in first-episode schizophrenia patients through image averaging Biological Psychiatry. 47: S106. DOI: 10.1016/S0006-3223(00)00615-6 |
0.304 |
|
| 1999 |
Keshavan MS, Hogarty GE. Brain maturational processes and delayed onset in schizophrenia. Development and Psychopathology. 11: 525-43. PMID 10532623 DOI: 10.1017/S0954579499002199 |
0.364 |
|
| 1999 |
Sweeney JA, Luna B, Haas GL, Keshavan MS, Mann JJ, Thase ME. Pursuit tracking impairments in schizophrenia and mood disorders: step-ramp studies with unmedicated patients. Biological Psychiatry. 46: 671-80. PMID 10472419 DOI: 10.1016/S0006-3223(99)00132-8 |
0.33 |
|
| 1999 |
Mac Master FP, Keshavan MS, Dick EL, Rosenberg DR. Corpus callosal signal intensity in treatment-naive pediatric obsessive compulsive disorders. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 23: 601-12. PMID 10390719 DOI: 10.1016/S0278-5846(99)00019-6 |
0.555 |
|
| 1999 |
Keshavan MS, Rosenberg DR. New trends in developmental neuroimaging in psychiatry. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 23: 557-60. PMID 10390715 DOI: 10.1016/S0278-5846(99)00026-3 |
0.463 |
|
| 1999 |
DeQuardo JR, Keshavan MS, Bookstein FL, Bagwell WW, Green WD, Sweeney JA, Haas GL, Tandon R, Schooler NR, Pettegrew JW. Landmark-based morphometric analysis of first-episode schizophrenia. Biological Psychiatry. 45: 1321-8. PMID 10349039 DOI: 10.1016/S0006-3223(98)00181-4 |
0.337 |
|
| 1998 |
Keshavan MS, Haas GL, Kahn CE, Aguilar E, Dick EL, Schooler NR, Sweeney JA, Pettegrew JW. Superior temporal gyrus and the course of early schizophrenia: progressive, static, or reversible? Journal of Psychiatric Research. 32: 161-7. PMID 9793869 DOI: 10.1016/S0022-3956(97)00038-1 |
0.362 |
|
| 1998 |
Figueroa Y, Rosenberg DR, Birmaher B, Keshavan MS. Combination treatment with clomipramine and selective serotonin reuptake inhibitors for obsessive-compulsive disorder in children and adolescents. Journal of Child and Adolescent Psychopharmacology. 8: 61-7. PMID 9639080 DOI: 10.1089/Cap.1998.8.61 |
0.492 |
|
| 1998 |
Keshavan MS, Rosenberg D, Sweeney JA, Pettegrew JW. Decreased caudate volume in neuroleptic-naive psychotic patients. The American Journal of Psychiatry. 155: 774-8. PMID 9619149 DOI: 10.1176/Ajp.155.6.774 |
0.6 |
|
| 1998 |
Rosenberg DR, Keshavan MS. A.E. Bennett Research Award. Toward a neurodevelopmental model of of obsessive--compulsive disorder. Biological Psychiatry. 43: 623-40. PMID 9582996 DOI: 10.1016/S0006-3223(97)00443-5 |
0.583 |
|
| 1998 |
Sanders RD, Forman SD, Pierri JN, Baker RW, Kelley ME, Van Kammen DP, Keshavan MS. Inter-rater reliability of the neurological examination in schizophrenia. Schizophrenia Research. 29: 287-92. PMID 9516670 DOI: 10.1016/S0920-9964(97)00103-5 |
0.31 |
|
| 1998 |
Master FPM, Rosenberg DR, Keshavan MS, Dick EL, Bagwell WW. 165. Callosal signal intensity and treatment-naive pediatric obsessive compulsive disorder Biological Psychiatry. 43. DOI: 10.1016/S0006-3223(98)90613-8 |
0.494 |
|
| 1997 |
Keshavan MS, Montrose DM, Pierri JN, Dick EL, Rosenberg D, Talagala L, Sweeney JA. Magnetic resonance imaging and spectroscopy in offspring at risk for schizophrenia: preliminary studies. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 21: 1285-95. PMID 9460092 DOI: 10.1016/S0278-5846(97)00164-4 |
0.609 |
|
| 1997 |
Rosenberg DR, Keshavan MS, Dick EL, Bagwell WW, MacMaster FP, Birmaher B. Corpus callosal morphology in treatment-naive pediatric obsessive compulsive disorder. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 21: 1269-83. PMID 9460091 DOI: 10.1016/S0278-5846(97)00163-2 |
0.581 |
|
| 1997 |
Rosenberg DR, Keshavan MS, O'Hearn KM, Dick EL, Bagwell WW, Seymour AB, Montrose DM, Pierri JN, Birmaher B. Frontostriatal measurement in treatment-naive children with obsessive-compulsive disorder. Archives of General Psychiatry. 54: 824-30. PMID 9294373 DOI: 10.1001/Archpsyc.1997.01830210068007 |
0.596 |
|
| 1997 |
Rosenberg DR, Sweeney JA, Squires-Wheeler E, Keshavan MS, Cornblatt BA, Erlenmeyer-Kimling L. Eye-tracking dysfunction in offspring from the New York High-Risk Project: diagnostic specificity and the role of attention. Psychiatry Research. 66: 121-30. PMID 9075276 DOI: 10.1016/S0165-1781(96)02975-7 |
0.511 |
|
| 1997 |
Dick EL, Kotwal R, Rosenberg DR, Bagwell WW, Kisler T, Sweeney J, Pettegrew JW, Keshavan MS. Abnormal signal intensity of corpus callosum in schizophrenia Schizophrenia Research. 24: 143. DOI: 10.1016/S0920-9964(97)82407-3 |
0.593 |
|
| 1996 |
Keshavan MS, Mulsant BH, Sweet RA, Pasternak R, Zubenko GS, Krishnan RR. MRI changes in schizophrenia in late life: A preliminary controlled study Psychiatry Research. 60: 117-123. PMID 8723302 DOI: 10.1016/0165-1781(96)02867-3 |
0.32 |
|
| 1996 |
Rosenberg D, Keshavan M, Bagwell W, Seymour A, O’Hearn K, Dick E, Birmaher B, Sweeney J. Caudate nucleus and putamen abnormalities in pediatric OCD Biological Psychiatry. 39: 606. DOI: 10.1016/0006-3223(96)84304-6 |
0.48 |
|
| 1996 |
Bagwell W, Minshew N, Rosenberg D, Sweeney J, Pettegrew J, Keshavan M. Developmental morphology of the corpus callosum in healthy and first-break schizophrenic subjects Biological Psychiatry. 39: 518. DOI: 10.1016/0006-3223(96)84013-3 |
0.511 |
|
| 1995 |
Keshavan MS, Miewald J, Haas G, Sweeney J, Ganguli R, Reynolds CF. Slow-wave sleep and symptomatology in schizophrenia and related psychotic disorders Journal of Psychiatric Research. 29: 303-314. PMID 8847657 DOI: 10.1016/0022-3956(95)00023-X |
0.304 |
|
| 1995 |
Quintana H, Keshavan M. Case Study: Risperidone in Children and Adolescents with Schizophrenia Journal of the American Academy of Child and Adolescent Psychiatry. 34: 1292-1296. PMID 7592266 DOI: 10.1097/00004583-199510000-00014 |
0.421 |
|
| 1995 |
Sweeney J, Quaranta B, Pogue-Geile M, Schooler N, Haas G, Keshavan M. Neuropsychological functions of prefrontal cortex are selectively impaired early in the course of schizophrenia Schizophrenia Research. 15: 136. DOI: 10.1016/0920-9964(95)95422-6 |
0.301 |
|
| 1995 |
Pieri J, Gupta BK, Bagwell WW, Haas GL, Sweeney JA, Schooler NR, Sanders RD, Pettegrew JW, Keshavan MS. MRI abnormalities in first-episode schizophrenia: Association with neurological impairment Schizophrenia Research. 15: 87-88. DOI: 10.1016/0920-9964(95)95272-B |
0.349 |
|
| 1995 |
Narayan C, Bagwell W, Haas G, Sweeney J, Schooler N, Pettegrew J, Keshavan M. Cerebellar and vermal volume in first-break schizophrenia Schizophrenia Research. 15: 86-87. DOI: 10.1016/0920-9964(95)95269-F |
0.323 |
|
| 1994 |
Mulsant BH, Stergiou A, Keshavan MS, Sweet RA, Rifai AH, Pasternak R, Zubenko GS. Schizophrenia in late life: elderly patients admitted to an acute care psychiatric hospital. Schizophrenia Bulletin. 19: 709-21. PMID 8303222 DOI: 10.1093/schbul/19.4.709 |
0.34 |
|
| 1994 |
Houlihan DJ, Flaum M, Arnold SE, Keshavan M, Alliger R. Further evidence for olfactory identification deficits in schizophrenia. Schizophrenia Research. 12: 179-82. PMID 8043528 DOI: 10.1016/0920-9964(94)90075-2 |
0.305 |
|
| 1994 |
Keshavan MS, Anderson S, Pettergrew JW. Is Schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited Journal of Psychiatric Research. 28: 239-265. PMID 7932285 DOI: 10.1016/0022-3956(94)90009-4 |
0.325 |
|
| 1994 |
Sanders RD, Keshavan MS, Schooler NR. Neurological examination abnormalities in neuroleptic-naive patients with first-break schizophrenia: preliminary results. The American Journal of Psychiatry. 151: 1231-3. PMID 7913586 DOI: 10.1176/AJP.151.8.1231 |
0.322 |
|
| 1993 |
Pettegrew JW, Keshavan MS, Minshew NJ. 31P nuclear magnetic resonance spectroscopy: neurodevelopment and schizophrenia. Schizophrenia Bulletin. 19: 35-53. PMID 8451612 DOI: 10.1093/schbul/19.1.35 |
0.312 |
|
| 1993 |
Keshavan M. Muscarinic Effects of Clozapine and Negative Symptoms Archives of General Psychiatry. 50: 835-835. PMID 8215809 DOI: 10.1001/Archpsyc.1993.01820220091014 |
0.365 |
|
| 1991 |
Caldwell C, Keshavan MS. Schizophrenia with secondary transsexualism. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 36: 300-1. PMID 1678310 DOI: 10.1177/070674379103600412 |
0.313 |
|
| 1990 |
Dassori AM, Mezzich JE, Keshavan M. Suicidal indicators in schizophrenia Acta Psychiatrica Scandinavica. 81: 409-413. PMID 2356762 DOI: 10.1111/J.1600-0447.1990.Tb05472.X |
0.387 |
|
| 1989 |
Keshavan M, Brar J, Asthana N, Singh K, Campbell K, Kambhampati R, Steingard S. Primitive reflexes in schizophrenia Biological Psychiatry. 25. DOI: 10.1016/0006-3223(89)91690-9 |
0.421 |
|
| 1988 |
Keshavan MS, Toone BS. Heterogeneity in sporadic schizophrenia. The British Journal of Psychiatry : the Journal of Mental Science. 152: 573-5. PMID 3167421 DOI: 10.1192/BJP.152.4.573C |
0.316 |
|
| 1988 |
Keshavan M, Toone BK, Marshall W, Shazly ME, Padi M. Neuroendocrine dysfunction in schizophrenia: a familial perspective. Psychiatry Research-Neuroimaging. 23: 345-348. PMID 3133684 DOI: 10.1016/0165-1781(88)90025-X |
0.398 |
|
| Show low-probability matches. |